curriculum vitae (.doc).doc.doc.doc

CURRICULUM VITAE

DEBABRATA MUKHERJEE, MD, MS, FACC

Business Address: Gill Foundation Professor of Interventional Cardiology

Associate Professor of Internal Medicine

Director of Cardiac Catheterization Laboratories

Director of Peripheral Intervention Program

Gill Heart Institute, Division of Cardiovascular Medicine

University of Kentucky

900 S. Limestone Street, 326B Wethington Building

Lexington, KY 40536-0200

Tel: 859-323-5630

Fax: 859-323-6475

Email: [email protected]

Home Address: 4390 Clearwater way

Lexington, KY 40515

Tel: 859 271 8472

Email: [email protected]

Education:

1988 MD, Government Medical College, Nagpur (India)

1990 ECFMG Certified

1990 FLEX

1990 Medical Council of Canada, Evaluating Examination

2001-03 Masters in Clinical Research (University of Michigan)

mailto:[email protected]

mailto:[email protected]

Professional Experience:

01/89 - 12/92 Fellow in Molecular Cardiology, The Cleveland Clinic

Foundation, Cleveland, Ohio.

01/93 - 02/96 Resident in Internal Medicine, The Cleveland Clinic Foundation,

Cleveland, Ohio.

06/96 – 06/99 Fellow in Clinical Cardiology, The Cleveland Clinic Foundation,

Cleveland, Ohio.

07/99 – 06/00 Fellow in Interventional Cardiology and Peripheral Vascular

Interventions, The Cleveland Clinic Foundation

07/00 – 06/01 Chief Interventional Cardiology Fellow, The Cleveland Clinic

Foundation

07/01 –09/04 Director of Peripheral Vascular Interventions for Cardiology,

Assistant Professor Division of Cardiology, University of

Michigan

10/04 – present Gill Foundation Professor of Interventional Cardiology, Director

of Peripheral Vascular Interventions

07/06-present Director Cardiac Catheterization Laboratories, University of

Kentucky

Grant Support:

2

American Heart Association Grant-in-Aid, 1999-2001 (Northeast

Ohio chapter)

American College of Cardiology Career Development Award,

2002-2003

Cleveland Clinic Foundation, PPAR agonists for the prevention of

adverse events following percutaneous coronary revascularization,

2002-2003, [Role – Local PI]

Astra Zeneca, A 104-Week, Open-Label, Multi-Center, Phase IIIb

Study Evaluating The Effect Of Treatment With Rosuvastatin 40

mg On Atherosclerotic Disease As Measured By Intravascular

Ultrasound And Quantitative Coronary Angiography In Subjects

Undergoing Coronary Angiography Who Have Coronary Artery

Disease, 2003-2004, [Role – Local PI]

PFIZER, A Phase 3, Multi-Center, Double-Blind, Randomized,

Parallel Group, Coronary Artery Intravascular Ultrasound

Evaluation of the Anti-Atherosclerotic Efficacy, Safety and

Tolerability of Fixed Combination CP-529,414/Atorvastatin

Administered Orally, Once Daily (QD) for 24 Months, Compared

with Atorvastatin alone, in subjects with Angiographically

Documented Coronary Heart Disease, 2004-2006, [Role – Local

PI]

Sanofi-Aventis, A randomized dose ranging Study of

Hexasaccharide including active control, in patients with Unstable

Angina or Non ST-segment Elevation Myocardial Infarction

scheduled to undergo Percutaneous Coronary Intervention

(SHINE), 2005 -2007, [Role – Local PI]

3

Conor Medsystems, COSTAR II trial (CObalt chromium STent

with Antiproliferative for Restenosis), 2005-2007, [Role – Local

PI]

NIH, GCRC Grant # M01 RR02602, Study # G5-0262 , Effect of

Mineralocorticoid Receptor Antagonism on Thrombosis,

Inflammation, and Oxidative Stress in Patients with Acute

Coronary Syndromes, 2005-2006, [Role – Co Principal

Investigator and Mentor]

Abbott Vascular CAPTURE – 2, Post-market surveillance to

document clinical outcomes involving the RX ACCULINK

Carotid Stent System and RX ACCUNET Embolic Protection

System (EPS) [Role – Local PI]

Licensure:

Ohio Medical license

Michigan Medical license

Kentucky Medical license

Board Certification:

1996 Internal Medicine

1999 Cardiovascular Diseases

2000 Interventional Cardiology

2005 Recertification in Internal Medicine

2005 Recertification in Cardiovascular Disease

Awards and Honors:

4

1979-86 Recipient of State Scholarship

1986 Recognition Award, Indian Council of Medical Research

1988 LN Jaiswal Gold Medal - First in University (MD)

1988 Sadiq Vali Gold Medal - First in Pediatrics (MD)

1988 DB Jaiswal Gold Medal - First in Medicine (MD)

1990 American Heart Association Research Fellowship

1990 Robert C Tarazi Fellowship Award for excellence in

cardiovascular research

1991 American Heart Association Research Fellowship

1997 Bristol – Myers Squibb Travel Award, American Heart

Association 70th Scientific Sessions

1998 Affiliate Travel Award, American college of Cardiology 47th

Scientific Sessions

1999 Young Investigator Award Finalist, American College of

cardiology 48th Scientific Sessions

1999 Astra-Zeneca Young Investigator Award Finalist

1999 First prize for Abstract, 9th Annual sessions of the Ohio chapter of

the American College of Cardiology

2000 Astra-Zeneca Young Investigator Award Finalist

2000 First prize for Abstract, 10th Annual sessions of the Ohio chapter of

the American College of Cardiology

2001 Joseph Cash Memorial Award for excellence in Health outcome

research

2002-03 American College of Cardiology/William F. Keating Career

Development Award for Hypertension and Peripheral Vascular

Disease

2003-2004 University of Michigan Cardiovascular Center McKay Research

Grant for Peripheral Arterial Disease

2006 Who’s Who in America

2007-08 Best Doctors in America

5

Memberships:

2005 – presentFellow of the Society for Vascular Medicine and Biology

2003 - present Fellow of the American College of Cardiology

1996 - present American College of Cardiology

1993 - present American College of Physicians

1993 - present American Medical Association

1991 - present International Federation for the Advancement of Genetic

Engineering and Biotechnology

1990 - present American Heart Association

1989 - present American Association for the Advancement of Science

1984 -1985 Indian Council of Medical Research

Teaching Activities:

2001 – 2002 Mentor, Undergraduate Research Opportunity Program (UROP)

2001 – 2004 Fellow supervisor, Cardiac Catheterization Laboratory at UMHS

2001 – 2004 Staff Attending, Cardiology Consult Service at UMHS

2001 – 2003 Medical Student Research Mentor

2004 – presentFellow supervisor, Cardiac Catheterization Laboratory at UK

2001 – presentStaff Attending, Cardiology Consult Service at UK

2005-present K30 Research Mentor for Dr Rohit Bhatheja

Professional Activities:

1997 - 1998 Clinical Events Committee, EPISTENT study

1998 – 1999 Clinical Events Committee, SYMPHONY study

2000 – 2001 Clinical Events Committee, TARGET study

2004 – 2005 Data Safety Monitoring Committee, STEEPLE Study

2004- 2005 Steering Committee, TENACITY study

2006– 2008 Steering Committee, MR PCI Study

6

http://www.svmb.org/

2006– present Data Safety Monitoring Committee, PRECISION Study

2006– present Steering Committee, MIDAS Study

2001–present Manuscript reviewer:

American Heart Journal

American Journal of Cardiology

American Journal of Hypertension

American Journal of Medicine

Atherosclerosis

Arteriosclerosis, Thrombosis and Vascular Biology

Circulation

Cleveland Clinic Journal of Medicine

European Heart Journal

Heart

Journal of the American College of Cardiology

JAMA

Joint Commission Journal on Quality and Patient Safety

Lancet

Nature Clinical Practice Cardiovascular Medicine

Stroke

The Journal of Rheumatology

Vascular Medicine

CMAJ

2003 National Heart Lung and Blood Institute Special Emphasis Panel

(Ancillary Pharmacogenetic Studies)

2003 Canadian Institute of Health Research (External reviewer)

2002–2006 Assistant Editor, ACC Current Journal Review

2006-present Associate Editor, ACC Cardiosource Review Journal

2003- present Editorial Board, Vascular Disease Prevention

2004-present International Editor, The Reviews

2005- present Editorial Board, International Journal of Angiology

7

2005- present Editorial Board, American Heart Journal

2006- present Editorial Board, Indian Heart Journal

2006- present Editorial Board, Recent Patents on Cardiovascular Drug Discovery

2006- present Editorial Board, American Journal of Managed Care

2007-present Editorial Board, The Open Health Services and Policy Journal

2005 -2008 Member, Cardiac Catheterization and Intervention Committee,

American College of Cardiology

2006-2009 American College of Cardiology i2 Summit Advisory Work Group

2007 -2010 Member, American College of Cardiology Task Force on

Clinical Expert Consensus Documents

2007 -2010 Heart Education Advisory and Research Team, (HEART),

Commonwealth of Kentucky

2008 – 2013 Editor–in-Chief, Cardiology Reviews

2008 - 2011 Member, Cardiac Catheterization and Intervention Committee,

American College of Cardiology

Publications:

1. Mukherjee D and Sen S. Collagen phenotypes during development and regression of

myocardial hypertrophy in spontaneously hypertensive rats. Circ Res 67: 1474-80, 1990.

2. Mukherjee D and Sen S. Alteration of collagen phenotypes in ischemic

cardiomyopathy. J Clin Inv 88: 1141- 46, 1991.

3. Mukherjee D, McTiernan CF and Sen S. Myotrophin induces early response genes

and causes enhanced cardiac gene expression. Hypertension 21: 142 - 48, 1993.

4. Mukherjee D and Sen S. Alteration of collagen phenotypes in hypertensive

hypertrophy: Role of blood pressure. J Mol Cell Cardiol 25: 185 - 96, 1993.

8

5. Mukherjee D, Lange P, Sferry C, Joseph J and Mehta A. Dyspnea, cough and chest

pain in a 35-year-old woman. Chest 107: 1460 - 62, 1995.

6. Sil P, Mukherjee D and Sen S. Quantification of myotrophin from spontaneously

hypertensive and normal rat hearts. Circ Res 76(6): 1020 - 27, 1995.

7. Steinhubl SR, Lauer MS, Mukherjee D, Moliterno DJ, Ellis SG, and Topol EJ.

Pretreatment with ticlopidine reduces non-q wave myocardial infarctions following

intracoronary stenting. J Am Coll Cardiol 32(5): 1366-70, 1998.

8. Mukherjee D, Bhatt DL, Roe MT, Patel V and Ellis SG. Direct Myocardial

Revascularization and Angiogenesis - How Many Patients Might be Eligible? Am J

Cardiol 84(5): 598-600, 1999.

9. Ellis SG, Cura FA and Mukherjee D. Prospects for therapeutic angiogenesis and

myogenesis in patients with advanced coronary disease. J Invasive Cardiol 11(10): 615-

17, 1999.

10. Mukherjee D and Moliterno DJ. Prompt Use of Reteplase (RetavaseTM) For Acute

Myocardial Infarction: Facilitating Percutaneous Coronary Intervention and Early

Hospital Discharge. J Invasive Cardiol [Clinical Case Update] Vol 2(2); March 2000

11. Bishay ES, McCarthy PM, Cosgrove DM, Hoercher KJ, Smedira NG, Mukherjee D,

White J, and Blackstone EH. Mitral valve surgery in patients with severe left ventricular

dysfunction. Euro J CardioThoracic Surg; 17:3:213-221, March 2000

12. Mukherjee D and Moliterno DJ. Applications of anti-platelet monitoring in the

catheterization laboratory. J Thrombosis and Thrombolysis 9(3): 293-301, April 2000

9

13. Mukherjee D and Moliterno DJ. Achieving tissue-level perfusion in the setting of

Acute Myocardial Infarction. Am J Cardiol 85 (8A): 39C – 46C, April 2000

14. Mukherjee D, Wong J, Griffin BP, Ellis SG, Porter T, Sen S, and Thomas JD. Ten

fold augmentation of endothelial uptake of vascular endothelial growth factor with

ultrasound after systemic administration.. J Am Coll Cardiol 35(6): 1678-86, May 2000.

15. Mukherjee D and Ellis SG. Use of rescue angioplasty for failed thrombolysis.

Cleveland Clinic J of Medicine 67(5): 341–352, May 2000

16. Mukherjee D, Nader S, Olano A, Garcia M, and Griffin BP. Improvement in right

ventricular systolic function after tricuspid valve surgery for isolated severe tricuspid

regurgitation. J Am Soc Echo 13(7):650-654, July 2000

17. Mukherjee D and Ellis SG. New options for untreatable coronary artery disease:

Angiogenesis and Laser revascularization. Cleveland Clinic J of Medicine 67(8): 577 –

583, August 2000.

18. Mukherjee D, Reginelli JP, Moliterno DJ, Yadav SJ, Schneider JP, Raymond R,

Whitlow PL, Franco I, and Ellis SG. Unexpected Mortality reduction with abciximab for

in-stent restenosis. J Invasive Cardiology 12(11): 540-544, Nov 2000

19. Mukherjee D and Yadav SJ. Carotid and cerebrovascular disease. Cardiology in

Review 8 (6): 322–332, Nov 2000

20. Mukherjee D and Moliterno DJ. Monitoring antiplatelet therapy: What is the best

method? Clinical Pharmacokinetics, 39(6): 445-458, Dec 2000

21. Moliterno DJ and Mukherjee D. Applications of monitoring platelet glycoprotein

IIb/IIIa antagonism and low-molecular-weight heparins in cardiovascular medicine. Am

Heart J, 140 (6 Pt 2):S136-S142, Dec 2000

10

22. Mukherjee D and Yadav SJ. Carotid angioplasty and stenting in high-risk patients.

Carotid Intervention 3 (1), 13-15, Jan 2001

23. Mukherjee D, Chew DP, Robbins M, Yadav J, Raymond RE, and Moliterno DJ.

Clinical Application of Procedural Platelet Monitoring During Percutaneous Coronary

Intervention Among Patients at Increased bleeding Risk. J Thrombosis and Thrombolysis

11, 143 – 146, April 2001

24. Mukherjee D, Roffi M, Kapadia S, Bhatt DL, Bajzer C, Ziada KM, Kalahasti V,

Hughes K, and Yadav JS Percutaneous Intervention for symptomatic vertebral artery

stenosis using coronary stents. J Inv Cardiology 13, 363-366, May 2001

25. Mukherjee D and Yadav SJ. Effect of Contralateral Occlusion on long-term Efficacy

of Endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS). Stroke

32(6):1443-1448 June 2001

26. Mukherjee D, Comella K, Bhatt DL, Roe MT, Patel V and Ellis SG. Clinical

Outcome of a Cohort of Patients Eligible for Therapeutic Angiogenesis or

Transmyocardial Revascularization Am Heart J 142: 72-74, July 2001

27. Mukherjee D and Yadav SJ. Update on peripheral vascular diseases: From smoking

cessation to stenting. Cleveland Clinic J of Medicine 68: 723-734, August 2001

28. Mukherjee D, Nissen SE, Topol EJ. Risk of Cardiovascular Events Associated With

selective COX-2 Inhibitors. JAMA 286: 954-959, August 2001

29. Chew DP, Bhatt DL, Robbins M, Mukherjee D, Roffi M, Schneider JP, Topol EJ,

and Ellis SG. Effect of clopidogrel added to aspirin before percutaneous coronary

intervention on the risk associated with C-reactive protein. Am J Cardiol 88(6): 672-674,

September 2001

11

30. Mukherjee D and Eagle KA. Increase in Peripheral Interventional Procedures by

Cardiologists – Are Patients being Served? Effective Clin Practice 4: 221-222, October

2001

31. Mukherjee D, Nissen SE, Topol EJ. COX-2 inhibitors and cardiovascular risk. We

defend our data and suggest caution. Cleveland Clinic J of Medicine 68: 963-964,

November 2001

32. Mukherjee D, Bhatt DL, Robbins M, Roffi M, Cho L, Reginelli J, Bajzer

C, Navarro F and Yadav JS. Renal artery end diastolic velocity and

renal artery resistance index as predictors of outcome after renal

stenting. Am J Cardiol 88(9): 1064-66, Nov 2001

33. Mukherjee D, Kalahasti V, Bhatt DL, Roffi M, Ziada KM, Hughes K, Bajzer C, and

Yadav JS. Self-expanding stents for carotid intervention: Comparison of Nitinol versus

stainless steel stents. J Inv Cardiol 13(11):732-735, Nov 2001

34. Mukherjee D. Therapeutic angiogenesis in the treatment of coronary artery disease.

Cardiology Update 1(1): 100-106, Dec 2001

35. Bhatt DL, Kapadia SR, Bajzer CT, Chew DP, Ziada KM, Mukherjee D, Roffi M,

Topol EJ and Yadav JS. Dual Antiplatelet Therapy with Clopidogrel and Aspirin after

Carotid Artery Stenting. J Inv Cardiol 13: 767-771, 2001

36. Mukherjee D, Nissen SE, Topol EJ. Cardiovascular Events and COX-2 Inhibitors.

JAMA. 286:2808-2813, Dec 2001

37. Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Heeschen C, Hamm CW,

Moliterno DJ, Cakliff RM, White HD, Kleiman NS, Theroux P, Topol EJ. Platelet

12

Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients with Non-ST-

Segment Elevation Acute Coronary Syndromes. Circulation 104:2767-71, Dec 2001

38. Mukherjee D, Roffi M, Bajzer C, and Yadav J. Endovascular Treatment of Carotid

Artery Aneurysms with Covered Stents. Circulation 104(24):2995, Dec 2001

39. Roffi M, Robbins MA, Mukherjee D, Bhatt DL, Bajzer C, Yadav JS. Carotid

stenting with emboli protection device. Images in Cardiovascular Medicine.

Kardiovaskulare Medizin 4:347-8, Dec 2001

40. Mukherjee D and Yadav J. Endovascular therapy for symptomatic vertebral artery

stenosis. Carotid Intervention 3 (3), 13-15, Jan 2002

41. Mukherjee D. Selective Cox-2 Inhibitors and Potential Risk of Cardiovascular

Events. Biochem Pharmacol 63 (5), 817-821, March 2002

42. Mukherjee D, Roffi M, and Yadav J. Endovascular Treatment of Carotid Artery

Aneurysms with stent grafts. J Invasive Cardiol 14: 269-72, May 2002

43. Mukherjee D and Topol EJ. Pharmacogenomics in cardiovascular diseases. Prog

Cardiovasc Dis 44 (6), 479 – 498, June 2002

44. Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Moliterno DJ, Heeschen C,

Hamm CV, Robbins MA, Kleinman NS, Théroux P, White HD, Topol EJ. Platelet

Glycoprotein IIb/IIa Inhibition in Acute Coronary Syndromes: Gradient of Benefit

Related to the Revascularization Strategy. European Heart Journal 23: 1441–1448,

September 2002

45. Mukherjee D and Eagle KA. Coronary revascularization prior to elective vascular

surgery: Does it reduce cardiac risk? J Vascular Surgery 36:644-645, September 2002

13

46. Mukherjee D, Lingam P, Chetcuti S, Grossman PM, Moscucci M, Luciano AE, and

Eagle KA. Missed Opportunities to Treat Atherosclerosis in Patients Undergoing

Peripheral Vascular Interventions: Insights From the University of Michigan Peripheral

Vascular Disease Quality Improvement Initiative (PVD-QI2) Circulation 106:1909-

1912; October 2002

47. Mukherjee D and Topol EJ. The Role of Low-Molecular Weight Heparin in

Cardiovascular Diseases. Prog Cardiovasc Dis 45(2): 139 –156, October 2002

48. Mukherjee D and Yadav J. Carotid artery intimal-medial thickness: indicator of

atherosclerotic burden and response to risk factor modification. Am Heart J 144; 753-

759, November 2002

49. Mukherjee D and Eagle KA. A common sense approach to peri-operative

evaluation. Am Fam Physician 66:1824-26, November 2002.

50. Mukherjee D and Yadav J. Percutaneous Treatment for Carotid Stenosis. Cardiology

Clinics 20(4): 589-97, November 2002

51. Chan AW, Bhatt DL, Wilkoff BL, Roffi M, Mukherjee D, Gray BH, Baizer CT, and

Yadav JS. Percutaneous treatment for pacemaker-associated superior vena cava

syndrome. Pacing Clin Electrophysiol 25(11):1628-33, November 2002

52. Mukherjee D, Gurm H, Tang WH, Roffi M Wolski K, Moliterno DJ, Guetta V,

Ardissinio D, Bode C, Steg G, Lincoff AM, and Topol EJ. Outcome of Acute ST-

segment Elevation Myocardial Infarction in Patients With Prior Coronary Artery Bypass

Surgery Treated with Combination Reduced Fibrinolytic Therapy and Platelet

Glycoprotein IIb/IIIa Inhibition. Am J Cardiol 90:1198–1203, December 2002

53. Mukherjee D, Nissen SE, and Topol EJ. Lack of cardioprotective effect of

naproxen. Archives of Internal Medicine 162(22): 2637 December 2002

14

54. Roffi M, Mukherjee D, Chew DP, Bhatt DL, Cho L, Robbins MA, Ziada KM,

Brennan DM, Ellis SG, Topol EJ. Lack of Benefit from Intravenous Platelet

Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous

Interventions of Aortocoronary Bypass Grafts: A Pooled Analysis of Five Randomized

Clinical Trials. Circulation 106: 3063 –3067, December 2002

55. Tamirisa K and Mukherjee D. Gene therapy in cardiovascular diseases. Curr Gene

Therapy 2 ( 4): 427-435, December 2002

56. Mukherjee D and Eagle KA. Cardiac risk in noncardiac surgery. Minerva

Cardioangiologica 50(6):607-19, December 2002

57. Mukherjee D, Mahaffey KW, Moliterno DJ, Harrington RA, Yadav J, Pieper KS,

Gallup D, Dyke C, Roe MT, Berdan L, Lauer M, Mänttäri M, White HD, Califf RC, and

Topol EJ. The promise of combined Low-Molecular-Weight Heparin and platelet

Glycoprotein IIb/IIIa Inhibition--Results from PARAGON B. Am Heart J 144: 995 –

1002, December 2002

58. Mukherjee D, and Topol EJ. COX-2: Where are we in 2003? Arthritis Research

5(1): 8 – 11, January 2003

59. Chan AW, Roffi M, Mukherjee D, Bajzer C, Abou-Chebl A, Ciezki J, Bhatt DL,

Ghaffari S, and Yadav J. Carotid brachytherapy for in-stent restenosis. Cathet

Cardiovasc Intervent 58(1): 86-92, January 2003

60. Cura FA, Kapadia SR, L'Allier PL, Ziada KM, Mukherjee D, Wolski KE, Yadav JS,

Brener SJ, Whitlow PL, Topol EJ and Ellis SG. Effect of uncoated stenting versus

balloon angioplasty alone of long coronary (>20 mm) versus shorter narrowings on One-

Year Event-Free survival, Am J Cardiol 91(5): 587-590, March 2003

15

61. Cho L, Roffi M, Mukherjee D, Bhatt DL, Bajzer C and Yadav JS. Superficial

femoral artery occlusion: Nitinol stents achieve better flow and reduces the need for

medications than balloon angioplasty alone J Inv Cardiology 15(4): 198-200, April 2003

62. Nallamothu BK Chetcuti S, Mukherjee D, Grossman PM, Kline-Rogers E, Werns S,

Bates ER; Moscucci M. The Impact of Troponin-I Elevation After Percutaneous

Coronary Intervention on Long-Term Survival. Am J Cardiol 91(10):1272-1274, May

2003.

63. Mukherjee D and Eagle KA. Predictors of Missed Opportunities for Reperfusion in

ST-segment-elevation Myocardial Infarction in the Global Registry of Acute Coronary

Events (GRACE). Cardiovascular Reviews & Reports 24:249-250, May 2003

64. Mukherjee D and Eagle KA. What's new in the treatment of acute coronary

syndromes? Emergency Medicine 35(5); 34 – 48, May 2003

65. Mukherjee D and Topol EJ. Pharmacogenomics in cardiovascular diseases.

Curr Probl Cardiol 28(5):317-347, May 2003

66. Mukherjee D. CVD, Pharmacogenomics and tailored medical therapy. Geriatric

Times 4(3), 13-14, June 2003

67. Mukherjee D and Eagle, KA. Perioperative Cardiac Assessment for Non-cardiac

Surgery: Eight Steps to the Best Possible Outcome. Circulation 107: 2771 - 2774, June

2003

68. Mukherjee D. Renal Artery Stenosis: Who to Screen and How to Treat? ACC Curr J

Rev 12(3): 70-75, June 2003

16

69. Mukherjee D and Eagle KA. Revised AHA/ACC Guidelines for the Management of

non-ST segment Elevation Acute Coronary Syndromes: Highlights, Clinical Applications

and Controversies. Current Cardiology Reports 5(4): 289-295, July 2003

70. Rajagopalan S, Pfenninger D, Kehrer C, Chakravarti A, Somers E, Pavlic R,

Mukherjee D, Brook R, D’Alecy LG and Kaplan MJ. Increased ADMA and Endothelin

1 levels in secondary Raynaud’s phenomenon: Implications for vascular dysfunction and

progression of disease. Arthritis Rheumatism 48 (7); 1992-2000, July 2003

71. Dey S and Mukherjee D. Clinical perspective on the role of anti-platelet therapy and

statins in patients with vascular diseases. Curr Vasc Pharmacology 1(3); 329-333,

September 2003

72. Bates ER, Mukherjee D and Lau WC. Drug-Drug Interactions Involving Antiplatelet

Agents. Eur Heart J 24 (19); 1707-1709, October 2003

73. Mukherjee D, Eagle KA, Smith DE, Kline-Rogers EM, Chetcuti S, Grossman PM,

Nallamothu BK, O'Donnell M, DeFranco A, Maxwell-Eward A, McGinnity J,. Meengs

WM, Patel K, and Moscucci M. Impact of Extra-Cardiac Vascular Disease on Acute

Prognosis in Patients Undergoing Percutaneous Coronary Interventions: Data From the

Blue Cross & Blue Shield of Michigan Consortium [BMC2] Am J Cardiol 92 (8), 972-

974, October 2003

74. Nallamothu BK, Chetcuti S, Mukherjee D, Eagle, KA, Grossman P M, Giri K,

McKechnie RS, Kline-Rogers E and Moscucci M. Long-term prognostic implication of

extracardiac vascular disease in patients undergoing percutaneous coronary intervention

Am J Cardiol 92 (8), 964-966, 2003

75. Mukherjee D and Topol EJ. Pharmaceutical Advertising versus Research Spending:

Are Profits more important than Patients. Am Heart J 146, 563-564, October 2003

17

http://www.sciencedirect.com/science?_ob=IssueURL&_tockey=%23TOC%234876%232003%23999079991%23462849%23FLA%23display%23Volume_92,_Issue_8,_Pages_901-1014_(15_October_2003)%23tagged%23Volume%23first%3D92%23Issue%23first%3D8%23Pages%23first%3D901%23last%3D1014%23date%23(15_October_2003)%23&_auth=y&view=c&_acct=C000007678&_version=1&_urlVersion=0&_userid=99318&md5=680eaea17ac41a46dd2c51a5f63f2c79


76. Rajagopalan S, Pfenninger D, Somers E, Kehrer C, Chakravarti A, Mukherjee D,

Brook R and Kaplan MJ Effects of cilostazol in patients with Raynaud's syndrome. Am J

Cardiol 92 (11), 1310-1315, December 2003

77. Mukherjee D and Eagle KA. Improving Quality of Care in the Real World –

Efficacy vs Effectiveness? Am Heart J 146 (6), 946-947, December 2003

78. Yee KC, Mukherjee D, Smith DE, Kline-Rogers EM, Fang J, Mehta RH,

Almanaseer Y, Akhras E, Cooper JV, and Eagle KA. Prognostic Significance of an

Elevated Creatine Kinase in the Absence of an Elevated Troponin I During an Acute

Coronary Syndrome Am J Cardiol 92 (12), 1442-1444, December 2003

79. Mukherjee D, Hsu A, Moliterno DJ, Lincoff AM, Goormastic M and Topol EJ. Risk

Factors for Premature Coronary Artery Disease and Determinants of Adverse Outcomes

after Revascularization in Patients ≤ 40 years of Age Am J Cardiol 92 (12), 1465-1467,

December 2003

80. Furman MI, Gore JM, Anderson FA, Budaj A, Goodman SG, Avezum A, López-

Sendón J, Klein W, Mukherjee D, Eagle KA, Dabbous OH, Goldberg RJ. Elevated

Leukocyte Count and Adverse Hospital Events in Patients with Acute Coronary

Syndromes: Findings from the Global Registry of Acute Coronary Events (GRACE). Am

Heart J 147 (1), 42-48, January 2004

81. Henke PK, Blackburn S, Proctor MC, Stevens J, Mukherjee D, Rajagopalan S,

Upchurch GR, Stanley JC, and Eagle KA. Patients undergoing infrainguinal bypass for

atherosclerotic vascular disease are underprescribed cardioprotective medications: Effect

on graft patency, limb salvage, and mortality J Vasc Surg 39(2): 357-65, February 2004

82. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, and Eagle KA.

Impact of Combination Evidence-based Medical Therapy on Mortality in Patients with

Acute Coronary Syndromes Circulation 109(6): 745 – 749, February 2004

18


83. Chen MS, Bhatt DL, Mukherjee D, Chan AW, Roffi M, Kapadia SR, Ziada KM,

Chew DP, Bajzer CT, and Yadav SJ. Safety of Simultaneous Bilateral Carotid Artery

Stenting Cathet Cardiovasc Intervent 61:437–442, April 2004

84. Sarkar S, Leaman DW, Gupta S, Sil P, Young D, Morehead A, Mukherjee D, Ratliff

N, Sun Y, Rayborn M, Hollyfield J, Sen S. Cardiac overexpression of myotrophin

triggers myocardial hypertrophy and heart failure in transgenic mice. J Biol Chem 279

(19):20422-34, May 2004

85. Mukherjee D and Eagle KA. Improving Quality of Cardiovascular Care in the Real

World – How can we Remove the Barriers Am J Managed Care 10(7): 471-472, July

2004

86. Mukherjee D and Eagle KA. Treatment of the Post-Myocardial Infarction Patient

Journal of Clinical Outcomes Management 11(7):436-443, July 2004

87. Mukherjee D and Eagle KA. Ischemia, Revascularization and Peri-operative

Troponin Elevation after vascular Surgery. J Am Coll Cardiol 44(3): 576-578, August

2004

88. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E and Eagle KA.

Optimal Therapy for Acute Coronary Syndromes: The More the Better? Circulation 110:

e52, August 2004

89. Fergus TS, Fazel R, Fang J, Chetcuti S, Smith DE, Kline-Rogers E, Munir K, Eagle

KA, and Mukherjee D. Presentation, Management, and Outcomes of Diabetic Patients

compared to Non-Diabetic Patients Admitted for Acute Coronary Syndromes HEART 90

(9):1051-1052, September 2004

19

90. Badr Al W, Mukherjee D, Kline-Rogers E, Mani O, Hussain S, Mehta R, Cooper

JV, and Eagle KA. Clinical Association between Renal Insufficiency and Positive

Troponin-I in Patients with Acute Coronary Syndrome Cardiology 102: 215-219,

September 2004

91. Mukherjee D, Oz M, Prager R and Eagle KA. Elective Coronary Revascularization:

An Iatrogenic Form of Acute Coronary Syndrome - How can Clinicians Reduce the

Risks? Am Heart J 148(3): 371-377, September 2004

92. Mukherjee D. Role of Emboli protection devices in native coronary and saphenous

vein graft percutaneous interventions. ACC Curr Jnl Rev 13(9), 32-35, September 2004

93. Mukherjee D. Current Clinical Perspectives on Myocardial Angiogenesis. Mol Cell

Biochem 264 (1-2): 157-167, September 2004

94. Saab FA, Eagle KA, Kline-Rogers E, Fang J, Otten R, and Mukherjee, D on behalf

of the Michigan Cardiovascular Outcomes Research and Reporting Program [MCORRP]

of the University of Michigan Cardiovascular Center. Comparison of Outcomes in Acute

Coronary Syndrome in Patients Receiving Statins within 24 Hours of onset - Versus - At

Later Times. American Journal of Cardiology 94(9), 1166-1168, November 2004

95. Mukherjee D and Bates ER. Current Role of Anti-thrombotic Agents in the

Treatment of Acute Coronary Syndromes. Semin Thromb Hemost 30(6): 627-632,

December 2004

96. Almanaseer Y, Mukherjee D, Kline-Rogers E, Mehta RH, Kesterson SK, Sonnad S,

Rogers B, Smith D, Furney S, Ernst R, McCort J and Eagle KE. Implementation of the

ACC/AHA Guidelines for Preoperative Cardiac Risk Assessment in a General Medicine

Preoperative Clinic: Improving Efficiency and Preserving Outcomes Cardiology 103(1):

24-29, January 2005

20

97. Mukherjee D, Kline-Rogers E, Fang J, Munir K, and Eagle KA. Lack of

Clopidogrel - CYP3A4 Statin Interaction in Patients with Acute Coronary Syndrome

HEART 91:23–26, January 2005

98. Mukherjee D, Wainess RM, Dimick JB, Cowan JA Jr, Rajagopalan S, Chetcuti S,

Grossman PM, and Upchurch Gr Jr. Variation in outcomes after Percutaneous Coronary

Intervention in the United States and Predictors of Peri-procedural Mortality Cardiology

103(3):143-147, February 2005

99. Fazel R, Fang J, Kline-Rogers E, Smith DE, Eagle KA, and Mukherjee D.

Prognostic Value of Elevated Biomarkers in Diabetic Compared to Non-Diabetic Patients

Admitted for Acute Coronary Syndromes HEART 91(3):388-90, March 2005

100. Mukherjee D, Fang J, Kline-Rogers E, Otten R and Eagle KA. Impact of

Combination Evidence-based Medical Therapy in Patients with Acute Coronary

Syndromes in Various TIMI Risk Groups HEART 91(3):381-382, March 2005

101. Evangelista A, Mukherjee D, Mehta RH, O’Gara PT, Fattori R, Cooper JV, Smith

DE, Oh JK, Hutchison S, Sechtem U, Isselbacher EM, Nienaber CA, Pape LA, Eagle KA

for the IRAD* Investigators. Acute Intramural Hematoma of the Aorta: A Mystery in

Evolution Circulation ;111:1063-1070, March 1st 2005

102. Mukherjee D, Meier D and Eagle KA. A 40-year old female with exertional angina

J Invasive Cardiology 17(3): 185-186, March 2005

103. Mukherjee D. Percutaneous coronary intervention versus coronary artery bypass

grafting in diabetic patients. Cardiology Clinics of North America 23(2):185-91, May

2005

104. Armstrong D, Kline-Rogers E, Jani SM, Goldman EB, Fang J, Mukherjee D,

Nallamothu BK, Eagle KA. Potential Impact of the HIPAA Privacy Rule on Data

21

Collection in a Registry of Patients With Acute Coronary Syndrome Arch Intern Med

165:1125-1129, May 2005

105. Mukherjee D and eagle KA. Aortic dissection – an Update. Curr Prob in

Cardiology 30(6): 281-326, June 2005

106. Mukherjee D. Optimizing Management of Patients with Coronary Artery Disease -

How do we get there? Eur Heart J 26(12): 1147 – 1149, June 2005

107. Mukherjee D, Munir K, Hirsch AT, Chetcuti S, Grossman PM, Rajagopalan SR,

Nallamothu BK, Moscucci M, Henke P, Kassab E, Sohal C, Riba A Person D, Luciano AE,

DeGregorio M, Patel K, Rutkowski KC, and Eagle KA. Development of a Multicenter

Peripheral Arterial Interventional Database: The Peripheral Vascular Disease Quality

Improvement Initiative (PVD-QI2). American Heart Journal 149(6):1003-1008, June

2005

108. Nallamothu B, Saint M, Saint S and Mukherjee D. Double Jeopardy. New England

J Med 353:75-80, July 2005

109. Ziada KM, Yadav JS, Mukherjee D, Lauer MS, Bhatt DL, Kapadia S, Roffi M,

Vora N, Tiong I, and Bajzer C. Management of Severe Cardiac and Carotid Disease:

Favorable Outcomes of Carotid Stenting Followed by Open Heart Surgery Versus

Combined Carotid Endarterectomy and Open Heart Surgery. Am J Cardiol 96 (4), 519-

523, August 2005

110. Cho L and Mukherjee D. Use of Hormone Replacement Therapy for the Prevention

of Cardiovascular Disease Events: A meta-analysis of randomized trials. Cardiology

104(3):143-147, August 2005

111. Keast RK, Eagle KA, Goldstein-Dunn J, Cox D, Michalak CG, Chetcuti S,

Grossman PM, Mukherjee D, Larin LR, Fetyko S, Denton TA and Moscucci M. Shelf-

22

http://www.sciencedirect.com/science?_ob=IssueURL&_tockey=%23TOC%234876%232005%23999039995%23603808%23FLA%23&_auth=y&view=c&_acct=C000001898&_version=1&_urlVersion=0&_userid=16764&md5=acdd8c855f53b0856529d20c1b93c293

Price Agreements: The Next Frontier in Competitive Bidding for Coronary Intervention

Supplies Journal of Cardiovascular Management 16(3):27-30, September 2005

112. Dumasia R, Eagle KA, Kline-Rogers E, May N, Cho L and Mukherjee D. Role of

PPAR- γ Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic

Individuals: A Cardiovascular Perspective. Current Drug Targets - Cardiovascular &

Haematological Disorders, 5(5):377-86, October 2005

113. Otten R, Kline-Rogers E, Meier D, Dumasia R, Fang J, May N, Resin Y, Armstrong

DF, Saab F, Petrina M, Eagle KA, and Mukherjee D. Impact of Prediabetic state on

Clinical Outcomes in patients with Acute Coronary Syndromes. HEART 91:1466-1468,

November 2005

114. Mukherjee D, Topol EJ, Bertrand ME, Kristensen SD, Herrmann HC, Neumann

FJ, Yakubov SJ, Bassand JP, McClure RR, Stone GW, Ardissino D, and Moliterno DJ

for the TARGET Investigators. Mortality at 1 year for the direct comparison of tirofiban

and abciximab during percutaneous coronary revascularization: Do Tirofiban and ReoPro

Give Similar Efficacy Outcomes at Trial (TARGET) 1-Year Follow-Up. Eur Heart J

26(23):2524-8, December 2005

115. Tsai TT, Nallamothu BK, Mukherjee D, Rubenfire M, Fang J, Chan P, Kline-

Rogers E, Patel A, Armstrong DF, Eagle KA and Goldberg AD. Effect of Statin Use in

Patients with Acute Coronary Syndromes and a Serum Low-Density Lipoprotein ≤ 80

mg/dl. Am J Cardiol 96(11):1491-3, December 2005

116. Mukherjee D, Evangelista A, Nienaber CA, Sechtem U, Suzuki T, Trimarchi S,

Llovet A, Myrmel T, O'Gara PT, Fang J, Cooper JV, Oh JK, Januzzi JL, Hutchison S,

Fattori R, Pape LA, Isselbacher EM, and Eagle KA. Implications of Periaortic

Hematoma in Patients with Acute Aortic Dissection: (From the International Registry of

Aortic Dissection) Am J Cardiol 96(12):1734-8, December 2005

23

117. Mukherjee D. Commentary 2 (Role and appropriate timing of invasive evaluation

in patients with unstable angina and NSTEMI. Evid Based Cardiovasc Med. 9(4):292-3,

December 2005

118. Mukherjee D, Topol EJ, Moliterno DJ, Brennan DM, Ziada K, Cho L, and

Steinhubl SR. Extra-Cardiac Vascular Disease and Effectiveness of Sustained

Clopidogrel Therapy HEART 92: 49 – 51, January 2006

119. Ramanathan PK, Eagle KA, Fang J, Kline-Rogers EM, Land B, Otten RF, Resin Y,

and Mukherjee D. Smoking Cessation in Patients with Acute Coronary Syndrome.

Indian Heart J; 58: 47-51, February 2006

120. Mukherjee D and Moliterno DJ. Brachytherapy for In-Stent Restenosis - A Distant

Second Choice to Drug-eluting Stent Placement. JAMA 295:1307-1309, March 2006

121. Froehlich JB, Mukherjee D, Avezum A, Budaj A, Kline-Rogers E, López-Sendón

J, Agnelli G, Allegrone J, Eagle, MD KA, Mehta RH and Goldberg RJ. Association of

Peripheral Artery Disease With Treatment and Outcomes in Acute Coronary Syndromes.

The Global Registry of Acute Coronary Events (GRACE). Am Heart J 151:1130-1135,

May 2006

122. Shishehbor MH, Topol EJ, Mukherjee D, Hu T, Cohen DJ, Stone GW, McClure R,

Roffi M, and Moliterno DJ. Clinical Outcome of Multivessel Coronary Intervention in

the Contemporary Percutaneous Revascularization Era. Am J Cardiol; 97:1585–1590,

June 2006

123. Cho L and Mukherjee D. Basic Cerebral Anatomy: The Intracranial and

Extracranial Vessels Catheter Cardiovasc Interv 68(1):104-111, June 2006

24

124. Das P, Ziada K, Steinhubl SR, Moliterno DJ, Hamdalla H, Jozic J and Mukherjee

D. Heparin-induced Thrombocytopenia and Cardiovascular diseases. Am Heart J

152(1):19-26, July 2006

125. Mukherjee D. Continuous Quality Improvement Initiatives in the Cardiac

Catheterization Laboratory – Can We have Our Cake and Eat It Too? Am J Managed

care 12(8):429-30, August 2006

126. Saab FA, Petrina M, Kline-Rogers E, Fang J, Otten R, Mukherjee D and Eagle

KA. Early Statin Therapy in Elderly Patients Presenting with Acute Coronary Syndrome

Causing Less Heart Failure. Indian Heart Journal: 321–324 August 2006

127. Das P, Moliterno DJ, Charnigo R, Mukherjee D, Sneed D, Steinhubl SR, Booth

DC, Ziada KM. Impact of Drug-Eluting Stents on Outcomes of Patients with End-Stage

Renal Disease Undergoing Percutaneous Coronary Revascularization. J Inv Cardiology

18(9):405-8, Sept 2006

128. Mukherjee D. Does a coxib-associated thrombotic risk limit the clinical use of the

compounds as analgesic anti-inflammatory drugs? Thrombosis and Haemostasis

96(4):407-12, October 2006

129. Rajagopalan S, Dellegrottaglie S, Furniss AL, Gillespie BW; Satayathum S,

Lameire N, Saito A, Akiba T, Jadoul M, Ginsberg N, Keen M, Port FK, Mukherjee D,

Saran R. Peripheral Arterial Disease in Patients with End-Stage Renal Disease -

Observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS)

Circulation114:1914-1922, October 2006

130. Harada RK, Eagle KA, Kline-Rogers EM, Fang J, Smith D, and Mukherjee D.

Low Utilization of Secondary Preventive Medications and its Potential Impact in Patients

25

with Chronic Kidney Disease and Acute Coronary Syndromes. Indian Heart Journal

2006; 58: 223–230, November 2006

131. Mukherjee D and Moliterno DJ. The Timely Coupling of Mechanical

Revascularization following Thrombolysis for Myocardial Infarction. Cardiology

107:337-339, January 2007

132. Mardikar HM and Mukherjee D. Current Endovascular Treatment of Peripheral

Arterial Disease. Prog Cardiovasc Nursing 22:31–37, March 2007

133. Latchamsetty R, Fang J, Kline-Rogers E, Mukherjee D, Otten RF, LaBounty TM,

Emery MS, Eagle KA, Froehlich JB. Prognostic Value of Transient and Sustained Rise

of In-hospital Creatinine on Outcomes of Patients Admitted with Acute Coronary

Syndrome. Am J Cardiol 99:939 –942, April 2007

134. Mukherjee D and Roffi M. Current Strategies With High Dose Tirofiban Expert

Opinion on Drug Metabolism and Toxicology 3(2):275-280, April 2007

135. Mukherjee D. Designing and Performing Large Multicenter Randomized Clinical

Trials in India: What do we need? Indian Heart J; 59: 113-115, April 2007

136. Roffi M, Brandle M, Robbins MA, and Mukherjee D. Current Perspectives on

Coronary Revascularization in the Diabetic Patient. Indian Heart J; 59: 124-136, April

2007

137. Bhatt DL, Chew DP, Grines C, Mukherjee D, Leesar M, Gilchrist IC, Corbelli JC,

Blankenship JC, Eres A, Steinhubl S, Tan WA, Resar JR, AlMahameed A, Abdel-Latif

A, Tang HW, Brennan D, McErlean E, Hazen SL, Topol EJ. Peroxisome proliferator-

activated receptor gamma agonists for the Prevention of Adverse events following

percutaneous coronary Revascularization--results of the PPAR study. American Heart

Journal 154(1):137-43, July 2007

26

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Topol%20EJ%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Hazen%20SL%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22McErlean%20E%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Brennan%20D%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Tang%20HW%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Abdel-Latif%20A%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Abdel-Latif%20A%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22AlMahameed%20A%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Resar%20JR%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Tan%20WA%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Steinhubl%20S%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Eres%20A%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Blankenship%20JC%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Corbelli%20JC%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Gilchrist%20IC%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Leesar%20M%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Mukherjee%20D%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Grines%20C%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Chew%20DP%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Bhatt%20DL%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus

138. Mukherjee D, Eagle KA, Kline-Rogers E, Feldman LJ, Juliard JM, Agnelli G,

Budaj A, Avezum A, Allegrone J, FitzGerald G, Steg PG, on behalf of the GRACE

Investigators. Impact of Prior Peripheral Arterial Disease and Stroke on Outcomes of

Acute Coronary Syndromes and Effect of Evidence-Based Therapies (from the Global

Registry of Acute Coronary Events) Am J Cardiol 100(1):1-6, July 2007

139. Mardikar HM, Hiremath MS, Moliterno DJ, Mathew R, Arora R, Deo D, Hiremath

JS, Deshpande NV, Khan A, Joseph J and Mukherjee D. Optimal Platelet Inhibition in

Patients undergoing PCI: Data from the Multicenter Registry of High-Risk Percutaneous

Coronary Intervention and Adequate Platelet Inhibition (MR PCI) Study. American

Heart Journal 154(2):344.e1-5, August 2007

140. Bhatheja R and Mukherjee D. Acute Coronary Syndromes: Non ST Segment

Elevation Myocardial Infarction. Critical Care Clinics of North America 23(4); 709-735,

October 2007

141. Mukherjee D and Eagle KA. The Use of Antithrombotics for Acute Coronary

Syndromes in the Emergency Department: Considerations and Impact Progress in

Cardiovascular Diseases, 50, (3): 167-180, November – December 2007

142. Mukherjee D and Pineda G. Extracranial Vertebral Artery Intervention. J Interv

Cardiol 20(6):409-16, December 2007

143. Mukherjee D and Moliterno DJ. Effectiveness of Drug-Eluting Stents in Real-

World Patients. JAMA 299(4):454-455, January 2008

144. Roffi M and Mukherjee D. Platelet glycoprotein IIb/IIIa receptor inhibitors – End

of an Era? Eur Heart J 29: 429-431, February 2008

27

145. Mukherjee D. Improving Adherence to Medications - Can We Make This Horse

Drink? Am Heart J 155: 589-590, April 2008

146. Mukherjee D and Roffi M. Glycoprotein IIb/IIIa Receptor Inhibitors in 2008: Do

They Still Have a Role? J Interv cardiology 21(2):118-21, April 2008

147. Mukherjee D. Nonsteroidal Anti-Inflammatory Drugs and the Heart: What Is the

Danger? Congest Heart Fail 14(2): 75-82, April 2008

148. Kim JS, Mukherjee D. Current status of carotid stenting. Curr Vasc Pharmacol

6(2): 143-7, April 2008

149. Mukherjee D. Antithrombotic Agents for Acute Coronary Syndromes.

Cardiovascular and Hematological Agents in Medicinal Chemistry 6 (2):130-141, April

2008

150. Mukherjee D. Optimal Treatment for In-stent Restenosis after BMS – DES, Coated

Balloon or Scalpel? Eur Heart J 29, 1595–1596, July 2008

151. Mukherjee D. Vertebral Artery Interventions. Am Heart Hosp J (in press)

152. Mardikar H, Deo D, Deshpande N, Mardikar M, Ghosh A, Munot K, Steinhubl S,

and Mukherjee D. Variability in platelet response to single daily dose of 150 mg enteric

coated aspirin in high risk population. J Assoc Physicians India (in press)

153. Shah A, Banerjee T and Mukherjee D. Coronary, peripheral and cerebrovascular

disease: a complex relationship. Herz (in press)

154. Mark DB, Berman DS, Lauer MS, Budoff MJ, Miller JM, Carr JJ, Morin RL,

Gerber TC, Mukherjee D, Hecht HS, Poon M, Hodgson JM, Rubin GD, Hlatky MA

Schwartz RS. ACCF/AHA/SCAI/SCCT/SAIP/ACR Clinical Expert Consensus

Document on CT Angiography. J Am Coll Cardiol (in press)

28

155. Mukherjee D. Peripheral and cerebrovascular disease. Best Practice & Research:

Clinical Endocrinology & Metabolism (in press)

156. Mukherjee D. Unraveling the Genetic Predisposition for Aortic Aneurysms - Is it

Time for Tailored Medicine. Am J Hypertens (in press)

Abstracts:

1. Mukherjee D and Sen S. Collagen phenotypes during development and regression of

myocardial hypertrophy in spontaneously hypertensive rats. Circulation 80(4): II -595,

1989 (Presented at the 62nd Scientific session of the American Heart Association).

2. Mukherjee D and Sen S. In Vitro transcriptional enhancement of myosin and

connexin (gap junction protein) by myotrophin. Circulation 82(4): III - 231, 1990

(Presented at the 63rd Scientific session of the American Heart Association).

3. Sen S, Sil P and Mukherjee D. Quantification of myotrophin from spontaneously

hypertensive rat heart. Circulation 84(4): II - 397, 1991 (Presented at the 64th

Scientific session of the American Heart Association).

4. Mukherjee D, McTiernan CF and Sen S. Effect of myotrophin on induction of proto -

oncogenes, ANF and contractile element transcript levels. Circulation 86(4) I - 626,

1992 (Presented at the 65th Scientific session of the American Heart Association).

5. Mukherjee D, Thekkumkara T, Sen G and Sen S. Ontogeny of myotrophin

mRNA in spontaneously hypertensive rat (SHR) hearts. Circulation 86(4) I - 96, 1992

(Presented at the 65th Scientific session of the American Heart Association).

29

6. Silver MJ, Chetcuti S, Mukherjee D, Malycky JL, Tomei DL, Umansky S, and

Nicolini FA. Use of a novel anti-apoptotic agent (LXR017) reduces infarct size following

ischemia-reperfusion in the canine myocardium. J Am Coll Cardiol 31(2) Suppl A, 66A,

1998 (Presented at the 47th Annual Scientific Session of the American College of

Cardiology).

7. Steinhubl SR, Lauer MS, Mukherjee D, Moliterno DJ, Ellis SG, and Topol EJ.

Pretreatment with ticlopidine reduces non-q wave myocardial infarctions following

intracoronary stenting. J Am Coll Cardiol 31(2) Suppl A, 100A, 1998 (Presented at the

47th Annual Scientific Session of the American College of Cardiology).

8. Wong J, Mukherjee D, Porter T, Young D, Sen S and Thomas J. Ultrasound

enhances PESDA linked oligonucleotide deposition into myocardial tissue. J Am Soc

Echo 11(5) RC, 1998 (Presented at the 9th Annual Scientific Session of the American

Society of Echocardiography).

9. Wong J, Mukherjee D, Porter T, Young D, Sen S and Thomas J. Ultrasound power

affects uptake of PESDA linked oligonucleotide deposition into myocardial tissue.

Circulation 98(17) I - 503, 1998 (Presented at the 71st Scientific session of the American

Heart Association).

10. Mukherjee D, Wong J, Griffin BP, Ellis SG, Porter T, Sen S, and Thomas JD. Ten

fold augmentation of myocardial uptake of vascular endothelial growth factor with

ultrasound after systemic administration. . J Am Coll Cardiol 33(2) Suppl A, 4A, 1999

(Presented at the 48th Scientific session of the American College of Cardiology as a

Young Investigator Award Finalist).

11. Mukherjee D, Wong J, Griffin BP, Ellis SG, Porter T, Vince DG, and Thomas JD.

Endothelial and Smooth Muscle Cell Migration Induced by Vascular Endothelial Growth

Factor with Ultrasound after Systemic Administration. J Am Coll Cardiol 33(2) Suppl A,

30

408A, 1999 (Presented at the 48th Scientific session of the American College of

Cardiology).

12. Mukherjee D, Olano A, Nader S, Garcia M, and Griffin BP. Improvement in right

ventricular systolic function after tricuspid valve surgery for isolated severe tricuspid

regurgitation. J Am Soc Echo 11(5) RC, 1999 (Presented at the 10th Annual Scientific

Session of the American Society of Echocardiography).

13. Mukherjee D, Wang K, Ellis SG, Silver M, Zhou X, Nimrod R, Topol EJ, and

Lincoff AM. Selective Inhibition of Factor Xa is more Efficient than Heparin at

Facilitating Coronary Thrombolysis in a Canine Model. J Am Coll Cardiol ; 35(2): Suppl

A, 373A, 2000 (Presented at the 49th Scientific session of the American College of

Cardiology).

14. Mukherjee D, Wong J, Griffin BP, Ellis SG, Sen S, Porter T, and Thomas JD.

Ultrasound Power Increases Myocardial Vascular Endothelial Growth Factor Uptake in a

Dose Dependent Manner. J Am Coll Cardiol ; 35(2): Suppl A, 494A, 2000 (Presented at

the 49th Scientific session of the American College of Cardiology).

15. Mukherjee D, Reginelli JP, Chew DP, Schneider JP, Raymond R, Whitlow PL,

Franco I, Topol EJ, and Ellis SG. A Potential New Indication for Thienopyridine ADP-

receptor Antagonists: In-stent Restenosis. J Am Coll Cardiol ; 35(2): Suppl A, 84A, 2000

(Presented at the 49th Scientific session of the American College of Cardiology).

16. Mukherjee D, Mahaffey KW, Sparapani R, Dyke C, Roe MT, Moliterno DJ,

Harrington R, Califf R and Topol EJ. The promise of combined LMW heparin and

Platelet glycoprotein IIb/IIIa inhibition – Results from PARAGON B. Circulation

102(18), II - 591, 2000 (Presented at the 73rd Scientific session of the American Heart

Association).

31

17. Mukherjee D, Reginelli JP, Moliterno DJ, Yadav SJ, Schneider JP, Raymond R,

Whitlow PL, Franco I, and Ellis SG. Mortality reduction with abciximab for in-stent

restenosis Circulation 102(18), II - 666, 2000 (Presented at the 73rd Scientific session of

the American Heart Association).

18. Cura FA, Kapadia SR, Ziada KM, Mukherjee D, Wolski KE, Bhatt DL, Yadav JS,

Whitlow PL Brener SJ, and Ellis SG. Lesion length and stent caution: Lessons from

randomized trials. Circulation 102(18), II - 387, 2000 (Presented at the 73rd Scientific

session of the American Heart Association).

19. Roffi M, Cura FA, Kapadia SR, Mukherjee D, Bhatt DL, Chew D, Robbins MA,

Albirini A, Wolski KE, and Ellis SG. Extending the temporal window for repeat target

vessel revascularization: Stenting loses ground versus balloon angioplasty after six

months. Circulation 102(18), II - 667, 2000 (Presented at the 73rd Scientific session of


20. Bhatt DL, Mukherjee D, Roffi M, Kapadia SR, Ziada KM, Chew DP, and Yadav JS.

Is Simultaneous Bilateral Carotid Artery Stenting Safe? J Am Coll Cardiol; 37(2): Suppl


Cardiology).

21. Roffi M, Chew DP, Mukherjee D, Bhatt DL, Robbins MA, Topol EJ. Glycoprotein

IIb/IIIa inhibitors in the medical management of unstable ischemic syndromes without

persistent ST-segment elevation: a meta-analysis of the randomized trials. J Am Coll

Cardiol; 37(2): Suppl A, 365A, 2001 (Presented at the 50th Scientific session of the

American College of Cardiology).

22. Roffi M, Bhatt DL, Mukherjee D, Chew DP, Ziada KM, Prosper DM, Ellis SG,

Topol EJ. Stents and glycoprotein IIb/IIIa blockade have no salutary effect on 30-day

outcome following percutaneous interventions of coronary bypass grafts. J Am Coll

32

Cardiol; 37(2): Suppl A, 68A, 2001 (Presented at the 50th Scientific session of the


23. Roffi M, Chan A, Chew DP, Robbins MA, Mukherjee D, Bhatt DL, Albirini A, Cho

L, Agah R, Topol EJ, Ellis SG. Stents and glycoprotein IIb/IIIa inhibitors do not improve

30-day outcome in bypass graft percutaneous interventions: a retrospective registry-based

analysis. J Am Coll Cardiol; 37(2): Suppl A, 77A, 2001 (Presented at the 50 th Scientific

session of the American College of Cardiology).

24. Roffi M, Mukherjee D, Bhatt DL, Chew DP, Ziada KM, Prosper DM, Ellis SG,

Topol EJ. Percutaneous coronary interventions of coronary bypass grafts have doubled

major adverse events. J Am Coll Cardiol; 37(2): Suppl A, 6A, 2001 (Presented at the 50th

Scientific session of the American College of Cardiology).

25. Robbins MA, Chew DP, Bhatt DL, Mukherjee D, Roffi M, Schneider JP, Topol EJ,

Ellis SG. ADP-antagonists therapy added to aspirin prior to coronary intervention

markedly attenuates the risk associated with baseline CRP status. J Am Coll Cardiol;

37(2): Suppl A, 28A, 2001 (Presented at the 50th Scientific session of the American

College of Cardiology).

26. Chew DP, Robbins MA, Bhatt DL, Mukherjee D, Roffi M, Topol EJ, Ellis SG. CRP

provides prognostic value in addition to ACC/AHA lesion score following PCI. J Am

Coll Cardiol; 37(2): Suppl A, 22A, 2001 (Presented at the 50th Scientific session of the


27. Kapadia S, Ziada KM, Crowe TD, Mukherjee D, Hobbs RE, Nissen SE, Tuzcu EM.

Total plaque Burden in early atherosclerosis: Can it be predicted by the most severe

lesion? J Am Coll Cardiol; 37(2): Suppl A, 63A, 2001 (Presented at the 50 th Scientific


33

28. Mukherjee D, Bhatt DL, Roffi M, Ziada KM, Hughes K, Bajzer C, Krieger D,

Whitlow P and Yadav JS. Treatment of Symptomatic Vertebral Artery Stenosis with

Angioplasty and Stenting. (Presented at the International Course on carotid Angioplasty,

Frankfurt/Offenbach, Germany, March 1-3, 2001).

29. Mukherjee D, Kalahasti V, Bhatt DL, Roffi M, Ziada KM, Hughes K, Bajzer C,

Krieger D, Whitlow P and Yadav JS. Self-expanding stents for carotid intervention:

Comparison of Nitinol versus stainless steel stents. (Presented at the International Course

on carotid Angioplasty, Frankfurt/Offenbach, Germany, March 1-3, 2001).

30. Roffi M, Bhatt DL, Mukherjee D, Chew DP, Ziada KM, Prosper DM, Ellis SG,

Topol EJ. Effects of stenting and glycoprotein IIb/IIIa on bypass graft interventions:

Pooled analysis of five randomized glycoprotein IIb/IIIa trials. (Presented at the Swiss

Society of Cardiology Meeting, March 23 –30, 2001). Kardiovaskulare Medizin; 4:

Suppl 3, 2001.

31. Bhatt DL, Kapadia SR, Chew DP, Mukherjee D, Ziada KM, Topol EJ, Yadav SJ.

Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting. Eur

Heart J; 22 (Suppl), p 634, 2001 (Presented at the 23rd Annual Congress of the

European Society of Cardiology 2001).

32. Zhou Z, Mukherjee D, Wang K, Zhou X, Tarakji K, Penn MS, Ellis SG. Intravenous

Infusion of Vascular Endothelial Growth Factor (VEGF) With Ultrasound Energy and

Echo Contrast Agent Improves Myocardial Blood Flow and Decreases Infarct Size in a

Canine Model of Chronic Myocardial Ischemia. Am J Cardiol 88 (5) Suppl 1, p 86G

[Presented at the Transcatheter Cardiovascular Therapeutics (TCT 2001) Meetings].

33. Chan AW, Quinn MJ, Mukherjee D, Moliterno DJ, and Ellis SG. Striking mortality

benefit of -blockade after successful elective percutaneous coronary intervention

Circulation 104(17), II - 711, 2001 (Presented at the 74th Scientific session of the

American Heart Association).

34

34. Mukherjee D, Bhatt DL, Robbins M, Roffi M, Cho L, Reginelli J, Bajzer C, Navarro

F, Yadav JS. Renal Artery end-diastolic velocity and renal artery resistance index

predicts outcome after renal artery stenting. Circulation 104(17), II–584, 2001 (Presented

at the 74th Scientific session of the American Heart Association).

35. Roffi M, Chew DP, Mukherjee D, Bhatt DL, Robbins MA, White JA, Heeschen C,

Hamm CW, Theroux P, Topol EJ. Glycoprotein IIb/IIIa inhibitors reduce mortality in

diabetic patients with unstable ischemic syndromes. Circulation 104(17), II - 782, 2001

(Presented at the 74th Scientific session of the American Heart Association).

36. Roffi M, Mukherjee D, Chew DP, Robbins MA, Cho L, Agah R, Chan AW, Quinn

MJ, Ellis SG. Procedural success and outcome of percutaneous coronary intervention of

arterial bypass grafts. Circulation 104(17), II - 776, 2001 (Presented at the 74th


37. Roffi M, Mukherjee D, Chan AW, Yadav SJ. Can ultrasound accurately predict

restenosis after carotid artery stenting? Circulation 104(17), II - 583, 2001 (Presented at

the 74th Scientific session of the American Heart Association).

38. Abou-Chebl A, Reginelli J, Mukherjee D, Bhatt D, Bajzer C, and Yadav J. Cerebral

hyperperfusion and intracranial hemorrhage following internal carotid artery stenting. J

Am Coll Cardiol; 39(5): Suppl A, 68A, 2002 (Presented at the 51st Scientific session of

the American College of Cardiology).

39. Chan A, Bhatt DL, Wilkoff BL, Roffi M, Mukherjee D, Gray B, Bajzer C, and

Yadav SJ. Percutaneous treatment for pacemaker lead related SVC syndrome. J Am Coll

Cardiol; 39(5): Suppl A, 99A, 2002 (Presented at the 51st Scientific session of the


35

40. Mukherjee D, Gurm H, Tang WH, Roffi M Wolski K, Moliterno DJ, Guetta V,

Ardissinio D, Bode C, Steg G, Lincoff AM, and Topol EJ. Improved Outcome of Acute

ST-segment Elevation Myocardial Infarction in Patients With Prior Coronary Artery

Bypass Surgery Treated with Combination Reduced Fibrinolytic Therapy and Platelet

Glycoprotein IIb/IIIa Inhibition. J Am Coll Cardiol; 39(5): Suppl A, 293A, 2002

(Presented at the 51st Scientific session of the American College of Cardiology).

41. Zhou Z, Mukherjee D, Wang K, Zhou X, Tarakji K, Ellis K, Chan A, Penn MS,

Ostensen J, Thomas JD, Garcia M, Topol EJ, and Ellis SG. Induction of Angiogenesis in

a Canine Model of Chronic Myocardial Ischemia With Intravenous Infusion of Vascular

Endothelial Growth Factor (VEGF) Combined With Ultrasound Energy and Echo

Contrast Agent. J Am Coll Cardiol; 39(5): Suppl A, 396A, 2002 (Presented at the 51st

Scientific session of the American College of Cardiology).

42. Sheikh MA, Navarro F, Mukherjee D, Bajzer C, Yadav J. Percutaneous Intervention

for Occlusive Subclavian Artery Disease. J Am Coll Cardiol; 39(5): Suppl A, 6A, 2002

(Presented at the 51st Scientific session of the American College of Cardiology).

43. Kapadia SR, Ziada KM, Mukherjee D, Nissen SE, and Tuzcu EM. Limitation of

Intravascular Ultrasound in Determining Artery Size: Role of Distension Pressure. J Am

Coll Cardiol; 39(5): Suppl A, 12A, 2002 (Presented at the 51st Scientific session of the


44. Chan AW, Roffi M, Mukherjee D, Bajzer C, Abou-Chebl A, Ciezki J, Bhatt DL,

Ghaffari S, and Yadav J. Bilateral carotid brachytherapy for in-stent restenosis

(Presented at the 13th annual meeting of the Society for Vascular Medicine and Biology

Annual Meeting, Boston, MA).

45. Mukherjee D, Smith D, Share D, Kline-Rogers E, Eagle KA, Chetcuti S, Grossman

P Michael, and Moscucci M. Significantly higher mortality in patients with IDDM

compared to patients with NIDDM and non-diabetics undergoing coronary interventions.

36

Eur Heart J 23: Suppl, pp 610, 2002 (Presented at the European society of Cardiology

Congress, September 2002, Berlin, Germany).

46. Mukherjee D, Smith D, Chetcuti S, Share D, Kline-Rogers E, Eagle KA, Grossman

P Michael, Moscucci, M. Lack of benefit of intravenous GP IIb/IIIa inhibitors in diabetic

patients undergoing PCI is explained by differences in baseline characteristics. Eur Heart

J 23: Suppl, pp 317, 2002 (Presented at the European society of Cardiology Congress,

September 2002, Berlin, Germany).

47. Mukherjee D, Smith D, Kline-Rogers E, Chetcuti S, Eagle KA, Grossman P

Michael, Share D, Moscucci M. Significant mortality benefit of prior beta-blocker use in

diabetic patients undergoing coronary intervention. Eur Heart J 23: Suppl, pp 317, 2002

(Presented at the European society of Cardiology Congress, September 2002, Berlin,

Germany).

48. Nallamothu BK, Chetcuti S, Mukherjee D, Grossman P M, Werns S, Bates E, and

Moscucci M. Impact of serum troponin-I elevation on long term survival following

percutaneous coronary intervention. Eur Heart J 23: Suppl, pp 155, 2002 (Presented at

the European society of Cardiology Congress, September 2002, Berlin, Germany).

49. Mukherjee D, Eagle KA, Smith DE, Kline-Rogers EM, O'Donnell M, De Franco A,

Maxwell-Eward A, McGinnity J, Meengs WM, Patel K, Moscucci M. Prognostic

Implications of Extra-Cardiac Vascular Disease in Patients Undergoing Coronary

Interventions: Insights From the Blue Cross & Blue shield of Michigan Consortium

[BMC2] Circulation 106(19), II - 492, 2002 (Presented at the 75th Scientific session of


50. Mukherjee D, Froehlich JB, Avezum A, Lopez-Sendon J, Kline-Rogers EM,

Johnson J, Mehta RH. Prognostic Implications of Peripheral Vascular Disease in Patients

with Acute Coronary Syndromes: Insights From the Global Registry of Acute Coronary

37

Events [GRACE] Circulation 106(19), II - 678, 2002 (Presented at the 75th Scientific

session of the American Heart Association).

51. Mukherjee D, Dey S, Lingam P, Chetcuti S, Grossman PM, Moscucci M,

Rajagopalan S, Luciano AE, Eagle KA. Predictors of Clinical Outcome in Patients

Undergoing Peripheral Vascular Interventions: Insights From the University of Michigan

Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2) J Am Coll

Cardiol; 41(6): Suppl A, 75A, 2003 (Presented at the 52nd Scientific session of the


52. Chetcuti S, Grossman PM, Mukherjee D, Lingam P, Kline-Rogers E, Share D,

Moscucci M. Improving Outcome of Percutaneous Coronary Intervention Through

Application of Guidelines and Benchmarking: Reduction of Blood Transfusion as a

Model J Am Coll Cardiol; 41(6): Suppl A, 527A, 2003 (Presented at the 52nd Scientific


53. Froehlich JB, Mukherjee D, Avezum A, Budaj A, Kline-Rogers EM, Lopez-Sendon

J, Johnson J, Eagle KA, Mehta RM. Quality of Care for Patients With Peripheral

Vascular Disease (PVD) During Acute Coronary Syndromes (ACS): Insights From the

Global Registry of Acute Coronary Events (GRACE). J Am Coll Cardiol; 41(6): Suppl

A, 252A, 2003 (Presented at the 52nd Scientific session of the American College of

Cardiology).

54. Rajagopalan S, Pfenninger D, Kehrer C, Somers E, Chakraborti A, McCune WJ,

Mukherjee D, Brook RD, Kaplan M. Cilostazol in Raynaud’s Disease-A Double-Blind

Placebo Controlled Clinical Trial. J Am Coll Cardiol; 41(6): Suppl A, 304A, 2003

(Presented at the 52nd Scientific session of the American College of Cardiology).

55. Moscucci M, Smith D, Mukherjee D, Montoye C, O'Donnell MJ, DeFranco AC,

Meengs WL, Maxwell-Eward A, McGinnity JG, Patel K, Share D, For The Blue Cross

Blue Shield of Michigan Cardiovascular Consortium (BMC2). Relationship Between

38

Time Of Day/Day Of Week And Outcomes In Patients Undergoing Primary PCI For

Acute Myocardial Infarction. J Am Coll Cardiol; 41(6): Suppl A, 541A, 2003 (Presented

at the 52nd Scientific session of the American College of Cardiology).

56. Zhou X, Mukherjee D, Zhou Z, Lincoff AM, Wang K . A combination of a

selective factor Xa inhibitor and full dose tPA is more effective than heparin and full

dose tPA at facilitating coronary thrombolysis in a canine model. Eur Heart J 23: Suppl,

pp 317, 2003 (Presented at the European society of Cardiology Congress, September

2003, Vienna, Austria).

57. Mukherjee D, Eagle KA, Smith DE, Kline-Rogers E, Lins S, Draus C, Share D,

Chetcuti S, Grossman PM, and Moscucci M. A Simple Risk Score for Predicting

Mortality in Diabetic Patients Undergoing Percutaneous Coronary Intervention

Circulation 108(17), IV-717, 2003 (Presented at the 76th Scientific session of the


58. Fox KA, Gore JM, Montalescot G, Mukherjee D, Gowda N, Steg G Ph, for the

GRACE Investigators. Impact of Insulin Treatment on Patients with ST-Segment

Elevation Myocardial Infarction. The Global Registry of Acute Coronary Events



59. Chetcuti SJ, Mukherjee D, Smith DE, Grossman PM, Bates ER, Duvernoy CJ,

Eitzman DT, and Moscucci M. Development of a Continuous Quality Improvement

Program for the Reduction of Contrast Nephropathy After Percutaneous Coronary

Intervention Circulation 108(17), IV-769, 2003 (Presented at the 76th Scientific session

of the American Heart Association).

60. Ziada KM, Yadav JS, Lauer MS, Bhatt DL, Kapadia SR, Mukherjee D, Roffi M,

Vora N, Tiong I and Bajzer C. Improved Outcomes with Carotid Stenting Prior to Open

Heart Surgery Compared to Combined Carotid Endarterectomy and Open Heart Surgery

39



61. Mukherjee D, Giri K, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, and Eagle

KA. Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients

With Acute Coronary Syndromes J Am Coll Cardiol; 43(5): Suppl A, 298A, 2004

(Presented at the 53rd Scientific session of the American College of Cardiology).

62. Nallamothu BK, Mukherjee D, Chetcuti S, Grossman PM, Dumasia R, Kline-Rogers

E, Pitt B, Eagle KA and Moscucci M. Combination Evidence-Based Therapy Improves

Survival After Percutaneous Coronary Intervention J Am Coll Cardiol; 43(5): Suppl A,

421A, 2004 (Presented at the 53rd Scientific session of the American College of

Cardiology).

63. Patel D, Chetcuti S, Grossman P M, Mukherjee D, and Bates E. Catheter Sequence

Rather Than Catheter Shape Determines The Frequency Of Cerebral Microemboli

During Cardiac Catheterization J Am Coll Cardiol; 43(5): Suppl A, 471A, 2004

(Presented at the 53rd Scientific session of the American College of Cardiology).

64. Saab F, Fang J, Kline-Rogers E, Otten R, Eagle KA, and Mukherjee D. Early

[within 24 hours] Statin Administration in Patients Presenting with Acute Coronary

Syndrome is Associated with Better Outcomes Compared to Delayed [after 24 hours]

Administration Circulation 110(17), Suppl III, III-498, 2004 (Presented at the 77 th


65. Harada RK, Kline-Rogers EM, Fang J, Otten R, and Mukherjee D. Use of Evidence-

Based Therapies in Patients with Chronic Kidney Disease Presenting with Acute

Coronary Syndrome and Its Impact on Clinical Outcomes. Circulation 110(17), Suppl

III, III-576, 2004 (Presented at the 77th Scientific session of the American Heart

Association).

40

66. Otten R, Kline-Rogers E, Meier DJ, Dumasia R, May N, Resin Y, Sweis R, Fang J,

Saab F, Petrina M, Eagle KA, and Mukherjee D. Impact of Prediabetic State on Clinical

Outcomes in Patients With Acute Coronary Syndrome J Am Coll Cardiol; 45(3): Suppl


Cardiology).

67. Mukherjee D, Eagle KA, Evangelista A, Sechtem U, Suzuki T, Trimarchi S, Llovet

A, Myrmel T, O'Gara PT, Fang J, Cooper JV, Oh JK, Januzzi JL, Hutchison S, Fattori R,

Pape LA, Isselbacher EM, Nienaber CA on behalf of the International Registry of Aortic

Dissection (IRAD) investigators. Implications of Periaortic Hematoma in Patients With

Acute Aortic Dissection: Insights From the International Registry of Aortic Dissection

(IRAD) J Am Coll Cardiol; 45(3): Suppl A, 380A, 2005 (Presented at the 54th Scientific


68. Tsai TT, Nallamothu BK, Grossman PM, Mukherjee D, Chetcuti S, Moscucci M,

and Bates ER. Does Facilitated Percutaneous Coronary Intervention Improve

Angiographic and Clinical Outcomes in ST Elevation Myocardial Infarction? A

Quantitative Review. J Am Coll Cardiol; 45(3): Suppl A, 243A, 2005 (Presented at the

54th Scientific session of the American College of Cardiology).

69. Mukherjee D, Eagle KA, Kline-Rogers E, Agnelli G, Budaj A, Avezum A,

Allegrone J, Steg Ph G on behalf of the GRACE Investigators. Acute Coronary

Syndrome as a Manifestation of Global Atherosclerosis – Impact of Prior Peripheral

Arterial Disease and Stroke on Clinical Outcomes. The Global Registry of Acute

Coronary Events (Presented at the European society of Cardiology Congress, September

2005, Stockholm, Sweden).

70. Jones N, Mukherjee D, Moscucci M, Froehlich JB, Chetcuti SJ, Munir K, Riba A,

Person D, Bishop M, Karve M, and Grossman PM. If Not Now, When? Underutilization

of Evidence Based Therapies in Patients Without Prior History of Coronary Artery

41

Disease Undergoing Peripheral Vascular Intervention. Circulation 112(17), Suppl II, II-

797, 2004 (Presented at the 78th Scientific session of the American Heart Association).

71. Latchamsetty R, Mukherjee D, Fang J, Kline-Rogers E, Otten R, Eagle KA,

Froehlich JB. Prognostic Value of Transient and Sustained Rise of In-Hospital Creatinine

on Outcomes of Patients Admitted with Acute Coronary Syndrome Circulation 112(17),

Suppl II, II-526, 2004 (Presented at the 78th Scientific session of the American Heart

Association).

72. Fazel R, Mukherjee D, Saab F, May N, Kline-Rogers EM, Rogers BC, Fang J,

Erickson S, Eagle KA. Improved Prescription of Evidence-Based Medications and

Maintenance of High Adherence to These Medications in Acute Coronary Syndrome

Patients After Implementation of Guidelines Applied in Practice J Am Coll Cardiol;

47(4): Suppl A, 254A, 2006 (Presented at the 55th Scientific session of the American


73. Das P, Moliterno DJ, Sneed D, Charnigo R, Mukherjee D, Steinhubl SR, Booth DC

and Ziada KM. Impact of Drug-Eluting Stents on Outcomes of Patients With End-Stage

Renal Disease Undergoing Percutaneous Coronary Revascularization J Am Coll Cardiol;

47(4): Suppl B, 28B, 2006 (Presented at the 55th Scientific session of the American


74. Jones NJ, Mukherjee D, Chetcuti SJ, Froehlich JB, Gurm H, Munir K, Luciano A,

Riba A, Kassab EH, Sohal C, Person D, Karve M, Bishop M, Dunning D, Schaefer A,

Moscussi and Grossman PM. Sex and Peripheral vascular Intervention: Does gender

impact peri-procedural outcomes? Circulation (Presented at the 7th Scientific Forum on

quality of care and outcomes research in cardiovascular disease and stroke).

75. Mukherjee D, Kline-Rogers E, Eagle KA, Feldman LJ, Juliard JM, Allegrone J, and

Steg PG. Acute coronary syndrome as a manifestation of global atherosclerosis: impact

of combination evidence-based therapy on mortality and morbidity in acute coronary

42

syndrome. The GRACE registry Eur Heart J, 27 (Suppl 1), 224, August 2006 (Presented

at the European society of Cardiology Congress, September 2006, Barcelona, Spain).

76. Das P, Ziada K, Hanna E, Falluji N, Booth D, Moliterno DJ and Mukherjee D. Do

octogenarians benefit from drug eluting stents? Am J Cardiol 98(8), Suppl 1, TCT 434,

October 2006 (Presented at the Transcatheter Cardiovascular Therapeutics Symposium,

October 2006, Washington, DC).

77. Dawson CB, Mukherjee D, Valgimigli M, Charnigo R, Walters DL, Danzi GB,

Bolognese L, Moliterno DJ, and Topol EJ. Meta-analysis of High-dose Single-bolus

Tirofiban versus Abciximab in Patients undergoing Percutaneous Coronary Interventions.

Circulation 114 (18), Suppl, II-647 (Presented at the 79th Scientific session of the

American Heart Association, 2006).

78. Mardikar HM, Hiremath MS, Moliterno DJ, Mathew R, Arora R, Deo D, Hiremath

JS, Deshpande NV, Khan A, Joseph J, Mukherjee D. Optimal Platelet Inhibition in

Patients Undergoing Percutaneous Coronary Intervention: Data From the MR PCI Study.

J Am Coll Cardiol; 49(9): Suppl B, 34B, 2007 (Presented at the 56 th Scientific session of

the American College of Cardiology).

79. Mardikar HM, Deo D, Deshpande NV, Mardikar M, Steinhubl SR and Mukherjee

D. Variability in platelet response to single daily dose of 150 mg aspirin in high risk

population. Eur Heart J, 28 (Suppl 1), 664, August 2007 (Presented at the European

society of Cardiology Congress, September 2007, Vienna, Austria).

Books

Rajagopalan S, Mukherjee D and Mohler E (eds). Manual of Vascular Medicine.

Philadelphia, PA: Lippincott Raven, 2004

43

Mukherjee D (ed) Pharmacological Therapies for Peripheral Vascular Diseases, London,

UK, Martin Dunitz, 2005

Mukherjee D (ed). ECG Cases pocket book. Germany, Borm Bruckmeier Publishing

LLC, 2006

Mukherjee D, Cho L, Moliterno DJ (eds). 900 Questions: An interventional cardiology

board review. Philadelphia, PA: Lippincott Raven, 2006

Mukherjee D, Rajagopalan S (eds). CT and MR Angiography of the Peripheral

Circulation: Practical Approach with Clinical Protocols, London, Taylor and Francis,

2007

Roffi M, Abou-Chebl A and Mukherjee D (eds). Carotid Stenting: Indications and

Results. Bremen, UNI-MED Publishing, 2008

Mukherjee D, Bates ER, Roffi, M and Moliterno DJ. Cardiac Catheterization, Coronary

& Peripheral Angiography, and Interventional Procedures. London, Informa Healthcare,

2009

Multimedia

CATHSAP 3, Associate Editor

ACCSAP 7, Section editor, Cardiac Catheterization and Interventional Cardiovascular

Medicine

Book Chapters:

1. Mukherjee D. Complications of Acute Myocardial Infarction. In Marso S, Griffin BP,

Topol EJ, eds. Manual of Cardiovascular Medicine. Philadelphia, PA: Lippincott Raven,

1999, pp 39 – 55.

44

2. Mukherjee D. Temporary Transvenous Pacemakers. In Marso S, Griffin BP, Topol

EJ, eds. Manual of Cardiovascular Medicine. Philadelphia, PA: Lippincott Raven, 1999,

pp 666 – 669.

3. Mukherjee D and Moliterno D. Bedside Platelet Monitoring. In Topol EJ eds. Acute

Coronary Syndromes (2nd Edition). New York, NY: Marcel Dekker, 2000, pp 563 –597

4. Mukherjee D, Wilkoff BL, Yadav JS. Angioplasty and Stenting of a Patient with

Superior Vena Cava Syndrome. In: Fifty Cases in Peripheral Intervention. ed:

Christopher White, MD, Martin Dunitz: London, 2002, pp 61-65

5. Mukherjee D and Yadav SJ. Cerebrovascular Diseases: Pathophysiology and

Management. In Fuster V ed. Assessing and modifying the vulnerable atherosclerotic

plaque. Armonk, NY: Futura Publishing, 2002, pp 29-55

6. Mukherjee D and Ellis SG. Rescue PCI for failed thrombolysis. In Cannon C, Tcheng

JE, eds. Primary Angioplasty in Acute Myocardial Infarction. Totowa, NJ: Humana

Press, 2002, pp 53-64

7. Mukherjee D and Yadav SJ. Status of randomized trials - SAPPHIRE. In Amor M,

Bergeron P, Mathias K and Raithel D, eds. Carotid Artery: Angioplasty and stenting

Turin, Italy: Edizioni Minerva Medica, 2002, pp 268-272

8. Mukherjee D. Device Genomics. In Topol EJ, Textbook of Interventional Cardiology

(4th Edition). Philadelphia, PA: W.B. Saunders, 2002, pp 1043-1052

9. Mukherjee D, Bates ER, and Hochman JS. Cardiogenic Shock – SHOCK Trial

Perspective. In Morrison D ed. High risk cardiac revascularization and clinical trials.

London, UK, Martin Dunitz, 2002, pp 327-335

45

10. Mukherjee D. Coronary Artery Disease In Cho L, Griffin B and Topol EJ (eds) The

Cardiology Intensive Board Review Question Book. Philadelphia, PA: Lippincott Raven,

2003, pp 105 – 157

11. Roffi M and Mukherjee D. Glycoprotein IIb/IIIa inhibitors. In de Marchena E and

Ferreira (eds), Interventional Cardiology Secrets. Philadelphia, PA: Hanley & Belfus,

Inc., 2003, pp 81-84

12. Mukherjee D and Bates ER. Acute ST elevation myocardial infarction. In Eagle KA,

Practical Cardiology. Philadelphia, PA: Lippincott Williams & Wilkins, 2003, pp 170-

187

13. Mukherjee D. Cardiovascular system. In Haessler I and Maute C (eds). Drug

Therapy Pocket 2003-2004. Hermosa beach, CA: Borm Bruckmeier Publishing, 2003, pp

11-42.

14. Mukherjee D and Yadav SJ. Carotid angioplasty and stenting. In Heuser RR and

Henry M. Textbook of peripheral vascular intervention. London, UK: Martin Dunitz,

2003, pp 333-339

15. Dumasia R and Mukherjee D. Adjunctive Pharmacology such as antithrombotics,

vasodilators, sedation/pain medication, pressors. In Bhatt DL (ed). Essential Concepts in

cardiovascular Intervention: Self Assessment and Review, Remedica Publishing 2003, pp

115-127

16. Mukherjee D and Eagle KA. Perioperative Evaluation and Management of Patients

with Known or Suspected Cardiovascular Disease Who Undergo Noncardiac Surgery. In

Fuster V, Roberts R, Alexander RW, O’Rourke R, King S, Nash I and Prystowski E

(eds) Hurst’s The Heart 11th Edition, Philadelphia, PA: McGraw-Hill, 2004, pp 2037-

2049

46

17. Mukherjee D and Asher C. (Section Editors) Miscellaneous Conditions. In: Roffi M,

Meier B, Topol EJ (eds): CVMstat®. A Comprehensive Handheld-Based Approach to

CardioVascular Medicine. Handheldmed Inc., Little Rock, AR, USA, 2004.

18. Mukherjee D and Eagle KA. Cardiac Risk in Non-cardiac Surgery. In: Roffi M,

Meier B, Topol EJ (eds): CVMstat®. A Comprehensive Handheld-Based Approach to

CardioVascular Medicine. Handheldmed Inc., Little Rock, AR, USA, 2004.

19. Mukherjee D. Diagnostic Catheter-based Vascular Angiography. In Rajagopalan S,

Mukherjee D and Mohler E (eds). Manual of Vascular Medicine. Philadelphia, PA:

Lippincott Raven, 2004, pp 28-47

20. Mukherjee D, Olin J, and Rajagopalan SR. Renovascular Disease – Diagnosis and

Management. In Rajagopalan S, Mukherjee D and Mohler E (eds). Manual of Vascular

Medicine. Philadelphia, PA: Lippincott Raven, 2004, pp 120-134

21. Roffi M and Mukherjee D. Approach to carotid Artery disease. In Rajagopalan S,

Mukherjee D and Mohler E (eds). Manual of Vascular Medicine. Philadelphia, PA:


22. Mukherjee D and Rajagopalan SR. Subclavian, Innominate and Axillary Arterial

Disease. In Rajagopalan S, Mukherjee D and Mohler E (eds). Manual of Vascular

Medicine. Philadelphia, PA: Lippincott Raven, 2004, pp 227-237

23. Mohler E, Mukherjee D, and Rajagopalan SR. Upper Extremity Deep Vein and

Superior Vena Cava (SVC) Thrombosis In Rajagopalan S, Mohler E and Mukherjee D

(eds). Manual of Vascular Medicine. Philadelphia, PA: Lippincott Raven, 2004, pp 325-

335

47

24. Dumasia R and Mukherjee D. Hemodialysis Access. In Rajagopalan S, Mukherjee D

and Mohler E (eds). Manual of Vascular Medicine. Philadelphia, PA: Lippincott Raven,

2004, pp 390-397

25. Mukherjee D and Cho L. Renal and mesenteric artery stenosis. In Bhatt DL (ed).

Handbook of peripheral and cerebrovascular intervention, Remedica Publishing 2004, pp

107-121

26. Mukherjee D and Moliterno D. Bedside Platelet Monitoring. In Topol EJ (ed).

Acute Coronary Syndromes (3rd Edition). New York, NY: Marcel Dekker, 2004, pp 481-

505

27. Mukherjee D and Eagle KA. Pre and Post-operative Management of Cardiovascular

Diseases and Risks in Patients with Peripheral Vascular Disease. In Abela G, Textbook

of Peripheral Vascular Diseases, Philadelphia, PA: W.B. Saunders, 2004, pp 353-364

28. Mukherjee D. Peripheral Vascular Occlusive Disease (PVOD) – Claudication. In

Upchurch G and Henke, P (eds). Clinical Scenarios of Vascular Surgery, Philadelphia,

PA: Lippincott Williams & Wilkins, 2005, pp 231-235

29. Mukherjee D. Arterial venous fistula in Groin Following Cardiac catheterization. In

Upchurch G and Henke, P (eds). Clinical Scenarios of Vascular Surgery, Philadelphia,

PA: Lippincott Williams & Wilkins, 2005, pp 259-264

30. Mukherjee D. Arthritis and Cardiovascular Events. In Topol EJ (ed). Textbook of

Cardiovascular Medicine – Update Series, Volume 8; Number 2, Philadelphia, PA:

Lippincott Williams & Wilkins, 2005, pp 1- 14

31. Mukherjee D and Moliterno DJ. Monitoring Anticoagulants in the Catheterization

Laboratory and in the ICU when using Combination Therapies. In Becker RC,

48

Harrington RA (eds) The Practice of clinical, interventional, and investigational

thrombocardiology. Philadelphia, PA: W.B. Saunders, 2005, pp 257-273

32. Mukherjee D and Eagle KA. Practical Principles of Quality Measurement and Cost

Effectiveness Analysis in Cardiovascular Medicine and Surgery. In ACCSAP VI

[American College of Cardiology], 2005, pp 1-22

http://www.acc.org/education/products/accsap6_chapters.htm

33. Mukherjee D. Lifestyle Changes and Risk factor Modification. In Mukherjee D (ed)

Pharmacological Therapies for Peripheral Vascular Diseases, London, UK, Taylor &

Francis, 2005, pp 3-10

34. Eagle K and Mukherjee D. Pharmacotherapy for Global Cardiovascular Risk

Reduction. In Mukherjee D (ed) Pharmacological Therapies for Peripheral Vascular

Diseases, London, UK, Taylor & Francis, 2005, pp129-138

35. Pitt B, Mukherjee D and Rajagopalan SR. Renin-Angiotensin-Aldosterone-System

[RAAS] Blockade in Peripheral Arterial Diseases. In Mukherjee D (ed) Pharmacological

Therapies for Peripheral Vascular Diseases, London, UK, Taylor & Francis, 2005, pp 65-

74

36. Mukherjee D and Eagle KA. Preoperative Cardiac Assessment In Zelenock,

Lumsden, Messina, Moneta, and Huber (eds) Mastery of Vascular and Endovascular

Surgery, Philadelphia, PA: Lippincott Williams & Wilkins, 2005, pp 47-54

37. Mukherjee D and Rosenfield K. Vertebral Artery Intervention. In Casserly I, Sachar

R and Yadav J (eds). The Manual of Peripheral Vascular Intervention. Philadelphia, PA:

Lippincott Williams & Wilkins, 2005, pp 110-119

49

http://www.acc.org/education/products/accsap6_chapters.htm

38. Mukherjee D and Eagle KA. Aortic Dissection In Bax, Kramer, Marwick and Wijns

(eds) Optimal Use of cardiovascular Imaging in Clinical Practice, Victoria, Australia,

Blackwell Publishing, Malden, MA, 2005, pp 49-60

39. Saraff KY, Mukherjee D, Moliterno DJ. Monitoring of Anti-thrombotic Drugs, In

Kristensen SD, Caternia R De, Moliterno DJ (eds). Therapeutic Strategies in

Thrombosis, Oxford, UK, Clinical Publishing Co., Inc., 2005, pp 359-383

40. Mukherjee D. Emerging Treatment Modalities in Coronary Artery Disease. In Kohli

K, Gupta M and Tejwani S (eds). Current Therapeutics in Clinical Practice, New Delhi,

India, Elsevier, 2006, pp 282-292.

41. Mukherjee D and Eagle KA. Assessment of Preoperative Risk. In Mulholland MW,

Doherty GM (eds). Complications in Surgery, Philadelphia, PA: Lippincott Williams &

Wilkins, 2006, pp 57-66

42. Falluji N and Mukherjee D. Cerebrovascular interventions. In Mukherjee D, Cho L,

Moliterno DJ (eds). 900 Questions: An interventional cardiology board review.

Philadelphia, PA: Lippincott Raven, 2006, pp 225-232

43. Cho L and Mukherjee D. Closure Devices. In Mukherjee D, Cho L, Moliterno DJ

(eds). 900 Questions: An interventional cardiology board review. Philadelphia, PA:


44. Mukherjee D, Moliterno DJ, Cho L Primary, Rescue and Facilitated Angioplasty In

Mukherjee D, Moliterno DJ, Cho L (eds). 900 Questions: An interventional cardiology

board review. Philadelphia, PA: Lippincott Raven, 2006, pp 88-96

45. Das P, Dutta M and Mukherjee D. Heparin-induced Thrombocytopenia In ACCSAP

VI [American College of Cardiology]

http://www.cardiosource.com/GenSAP/Chapter.asp?ProductID=40&ChapterID=2207

50


46. Das P, Dutta M and Mukherjee D. Hypercoaguable Syndromes. In ACCSAP VI

[American College of Cardiology]


47. Mukherjee D and Januzzi JL. Long-term Medical Therapy in Aortic Dissection In

Baliga, Isselbacher, Nienaber and Eagle (eds) Aortic Dissection, New York, NY, Kluwer

Academic Publishers, 2007, pp 193-198

48. Mukherjee D and Eagle KA. Prevention of Aortic Dissection In Baliga, Isselbacher,

Nienaber and Eagle (eds) Aortic Dissection, New York, NY, Kluwer Academic

Publishers, 2007, pp 347-350

49. Falluji N and Mukherjee D. Lower extremity interventions. In Topol EJ, Textbook

of Interventional Cardiology, 5th Edition. Philadelphia, PA: W.B. Saunders, 2007, pp

689-708

50. Das P and Mukherjee D. Bioabsorbable stents. In Topol EJ, Textbook of

Interventional Cardiology, 5th Edition. Philadelphia, PA: W.B. Saunders, 2007, pp 601-

618

51. Ziada K and Mukherjee D. Peri-Procedural MI and Emboli Protection. In Topol EJ,

Textbook of Interventional Cardiology, 5th Edition. Philadelphia, PA: W.B. Saunders,

2007, pp 491-512

52. Mukherjee D and Eagle KA. Perioperative Evaluation and Management of Patients

with Known or Suspected Cardiovascular Disease Who Undergo Noncardiac Surgery. In

Fuster V, O’Rourke R, Walsh RA and Poole-Wilson PA (eds) Hurst’s The Heart 12th

Edition, Philadelphia, PA: McGraw-Hill, 2007, pp 2038-2047

51


53. Mukherjee D and Rajagopalan SR. X-Ray Contrast Agents and Contrast Timing

Considerations. In Mukherjee D, Rajagopalan S (eds). CT and MR Angiography of the

Peripheral Circulation: Practical Approach with Clinical Protocols, London, Taylor and

Francis, 2007, pp 53-62

54. Nallamothu B, Mukherjee D and Bates ER. Acute ST elevation myocardial

infarction. In Eagle KA, Practical Cardiology (2nd Edition). Philadelphia, PA: Lippincott

Williams & Wilkins, 2003, pp 196-218

55. Mukherjee D and Moliterno DJ. Heparin-induced Thrombocytopenia In CATHSAP

3 [Catheterization and Interventional Cardiology Self-Assessment Program], 2008

http://www.acc.org/education/products/cathsap3.htm

56. Mukherjee D and Moliterno DJ. Hypercoagulable Disorders In CATHSAP 3

[Catheterization and Interventional Cardiology Self-Assessment Program], 2008


57. Moliterno DJ and Mukherjee D. Chronic Total Occlusion In CATHSAP 3

[Catheterization and Interventional Cardiology Self-Assessment Program], 2008


58. Mukherjee D. Aortic Dissections In CATHSAP 3 [Catheterization and

Interventional Cardiology Self-Assessment Program], 2008


59. Pineda G and Mukherjee D. Lower extremity: Contrast imaging studies. In Richard

Heuser and Michel Henry (Eds) Textbook of Peripheral Vascular Interventions 2nd

edition, London, Taylor and Francis, 2008

52





60. Mukherjee D. Cardiovascular Disease in patients with carotid stenosis. In Roffi M,

Abou-Chebl A and Mukherjee D (eds). Carotid Stenting: Indications and Results.

Bremen, UNI-MED Publishing, 2008

61. Mukherjee D. Carotid Stenting Equipment. In Roffi M, Abou-Chebl A and

Mukherjee D (eds). Carotid Stenting: Indications and Results. Bremen, UNI-MED

Publishing, 2008

62. Mukherjee D. Secondary Prevention and follow-up. In Roffi M, Abou-Chebl A and

Mukherjee D (eds). Carotid Stenting: Indications and Results. Bremen, UNI-MED

Publishing, 2008

63. Das P and Mukherjee D. Coronary artery disease in Peripheral Arterial Disease. In

Dieter RS (ed) Peripheral Arterial Disease. McGraw-Hill Professional, 2008

64. Dawson CB, Mukherjee D and Moliterno DJ. High Dose Tirofiban In Waksman R

and Ajani A (eds) Pharmacology in the Cath Lab, Blackwell Publishing, 2008

65. Mukherjee D and Roffi M. Coronary Artery Disease In Cho L and Griffin B (eds)

The Cardiology Intensive Board Review Question Book (2nd Edition). Philadelphia, PA:

Lippincott Raven, 2008

66. Mukherjee D. Right and Left Heart Catheterization, Myocardial, Valvular, and

Pericardial Disease In ACCSAP 7 [American College of Cardiology]

67. Mukherjee D. Coronary Angiography: Indications, Contraindications, and

Complications In ACCSAP 7 [American College of Cardiology]

68. Mukherjee D. Catheter Selection, Coronary Artery Anatomy and Anomalies,

Physiologic Assessment of Coronary Stenoses, and Intravascular Ultrasound In ACCSAP

7 [American College of Cardiology]

53

69. Roffi M, Mukherjee D and Windecker S. Percutaneous Coronary Intervention,

Coronary Artery Stents In ACCSAP 7 [American College of Cardiology]

70. Dunn S, Macauley T and Mukherjee D. Antiplatelet and Antithrombotic Agents

During Percutaneous Coronary Intervention In ACCSAP 7 [American College of

Cardiology]

71. Pineda G and Mukherjee D. Balloon Angioplasty, Atherectomy, Distal Embolic

Protection Devices, and Total Occlusion Crossing Devices In ACCSAP 7 [American

College of Cardiology]

72. Das P and Mukherjee D. High-Risk Subsets for Percutaneous Coronary

Intervention and Complications In ACCSAP 7 [American College of Cardiology]

73. Roffi M, Mukherjee D and Windecker S. Restenosis and Stent Thrombosis In

ACCSAP 7 [American College of Cardiology]

74. Roffi M and Mukherjee D. Peripheral Arterial Angiography, Carotid Angiography

and Interventions In ACCSAP 7 [American College of Cardiology]

75. Mukherjee D. Training Standards and Proficiency In ACCSAP 7 [American College

of Cardiology]

76. Mukherjee D. Renal Artery Disease In Garcia M (ed) Textbook of Non-Invasive

Cardiovascular Imaging: The Modern Approach to Cardiovascular Diagnosis and

Therapeutic Guidance (1st Edition). Philadelphia, PA: Lippincott Raven, 2009

77. Mukherjee D, Jacobs BS, Hickenbottom S and Eagle KA. Nonatherosclerotic Large

Vessel Disease. In Cho L, Schneck MJ (eds) Cerebrovascular Disease – A cardiac

perspective, Elmsford, NY: Blackwell/Futura, 2009

54

Invited Lectures

Ultrasound mediated enhancement of myocardial uptake of systemically applied growth

factors (Angiogenesis and Direct Myocardial Revascularization National Meeting, 1999)

Therapeutic Angiogenesis and newer modalities of therapy in the treatment of coronary

artery disease (Cleveland Clinic Foundation Internal medicine Grand rounds, July 6,

2000)

Peripheral vascular diseases: Patient presentation, evaluation and current therapy options

(Cleveland Clinic Cardiology Board Review, September 26, 2000)

Carotid Stenting in High-Risk Patients (International Society of Endovascular Therapy,

Miami, Jan 23, 2001)

Update on Carotid Clinical Trials: SAPPHIRE (International Society of Endovascular

Therapy, Miami, Jan 23, 2001)

Newer modalities of therapy in the treatment of Coronary Artery Disease (University of

Michigan cardiology Grand rounds, Feb 12, 2001)

Significant renal artery stenosis requires medical management (9th Annual New Devices

Seminar, June 30 – July 3, Orlando, Florida)

Angiographic Techniques and Anatomy for Cerebrovascular Disease (9th Annual New

Devices Seminar, June 30 – July 3, Orlando, Florida)

COX-2 inhibitors and cardiovascular risk (Cybersession on Heart.org, 22nd Aug 2001)

55

http://dev.cybersessions.com/conference/22aug01/

Carotid Stenting: Techniques & cerebral protection - current and future devices (3rd

Annual Great Lakes Endovascular Symposium, October 20, 2001, Dearborn, Michigan)

Has carotid stenting eclipsed endarterectomy? (3rd Annual Great Lakes Endovascular

Symposium, October 20, 2001, Dearborn, Michigan)

Therapeutic Angiogenesis (53rd Annual Conference of the Cardiological Society of

India, December 6 - 9, 2001, Hyderabad, India)

Coronary Catheterization and Intervention: Why diabetics are different (University of

Michigan, Update in Internal Medicine, May 2-4, 2002)

Diagnosis and Management of Renal and Peripheral Vascular Diseases (Cleveland Clinic

Foundation, Cleveland, Ohio, Cardiology Grand Rounds, May 31, 2002)

Advances in Interventional Cardiology: Drug eluting stents and emboli protection

devices (University of Michigan Cardiovascular Center Nursing Symposium, June 3-4,

2002)

Management of Peripheral Vascular Diseases (Henry Ford Hospital and Vascular

Institute, Detroit, Michigan, Cardiology Grand Rounds, July 24, 2002)

Creating New Paradigms in the Treatment of Acute Coronary Syndromes. (Michigan

State University Primary Care Symposium, August 16th, 2002)

Acute Coronary Syndromes (Congdon Lecture Series, Genesys Medical Center, October

9th, 2002)

Peripheral Vascular Interventions: Current Role of Cardiologists (University of Michigan

56

Cardiology Grand Rounds, December 3rd, 2002)

Peripheral Vascular Interventions: Current Role for Cardiology (The 25th annual

American College of Cardiology conference at Big Sky, Feb 19th 2003, Montana)

Role and Controversies of Antithrombin Therapy in Acute Coronary syndromes (The 4 th

annual Antithrombotic Therapy Symposium at Dearborn, Michigan, March 5th, 2003)

Clinical Impact of Current Acute Coronary Syndrome Studies for the Primary Care

Physician (Primary Care Update, Muskegon, Michigan, March 19th, 2003)

Percutaneous Treatment of PVD (Controversies in Peripheral Vascular Disease, Loyola

University School of Medicine, March 29th, 2003)

Carotid and Renal Artery Stenosis: Endovascular Therapy (Henry Ford Hospital and

Vascular Institute, Detroit, Michigan, Cardiology Grand Rounds, July 29th, 2003)

Peripheral Vascular Disorders (Internal Medicine Grand Rounds, McLaren Regional

Medical Center, Flint, Michigan, September 5th, 2003)

Peripheral Arterial Disease (Primary Care Update, Metropolitan Hospital, Grand Rapids,

Michigan, November 1st, 2003)

Further Management of a Patient Discharged with the Diagnosis “Acute Coronary

Syndrome” (Updates in Primary Care IV – Office cardiology for the Primary care

Physician, November 22nd, 2003)

Peripheral Arterial Disease – Epidemiology, Diagnosis and Management – (State of the

Heart address at the Loyola University Medical center, November 26th, 2003)

Diabetes, Coronary Artery Disease and Revascularization - (University of Michigan

57

Cardiology Grand Rounds, December 9th, 2003)

Risk factors and their modification: Can ischemic events be avoided? – (Peripheral

Arterial Disease – The Silent Killer, January 10th, Jobst Vascular Center, Toledo, Ohio)

Pharmacotherapy for global cardiovascular risk reduction and PAD – (Peripheral Arterial

Disease – The Silent Killer, January 10th, Jobst Vascular Center, Toledo, Ohio)

Antiplatelet Agent and peripheral arterial disease – (St Mary Mercy Hospital, Livonia,

Michigan, Internal Medicine Grand Rounds 4th February 2004)

Beta-blockers must be used to reduce cardiovascular mortality in diabetics – (Coronary

Artery Disease 2004, February 20th – 22nd, Mumbai, India)

Effective Antiplatelet therapy – (Coronary Artery Disease 2004, February 20 th – 22nd,

Mumbai, India)

Limb Ischemia – (Coronary Artery Disease 2004, February 20th – 22nd, Mumbai, India)

Carotid Stenting – Anatomy (American College of Cardiology Interventional

symposium, 53rd Scientific session of the American College of Cardiology, March 9th,

2004, New Orleans, LA)

Percutaneous Revascularization: Well Beyond the Coronary Arteries (Kentucky Chapter

of the American college of cardiology - What's New in Clinical Cardiology? Exploring

Facts and Fiction, October 9th, 2004, Lexington, Kentucky)

Invited Discussant – REACT Trial (American Heart Association Scientific Sessions,

November 7th, 2004, New Orleans, LA)

Diabetes, Coronary Artery Disease and Revascularization (University of Kentucky

58

Cardiovascular seminar series, January 28th, 2005, Lexington, Kentucky)

Expectation of Trial Design: Cardiovascular Perspective (Cardiovascular Effects of

Selective Cox-2 Inhibition: Is there a Class Effect? International Cox-2 Study group

Meeting, January 28th – 30th, 2005, Washington, DC)

Aortic dissection: Evaluation and Management – (Coronary Artery Disease 2005,

February 10th – 13th, Agra, India)

Pre-op Evaluation of the Non-cardiac Surgery Patient – (Coronary Artery Disease 2005,

February 10th – 13th, Agra, India)

Emboli Protection Devices in PCI – (Coronary Artery Disease 2005, February 10 th – 13th,

Agra, India)

Peripheral Vascular Disease – Pathophysiology, Diagnosis and Management – (Internal

Medicine Grand rounds, University of Kentucky, April 29th 2005)

Peripheral Vascular Disease – Contemporary Management – (Cardiology Grand rounds,

St John Hospital, Michigan, July 27th 2005)

Cardiology Urgencies and Emergencies for the Hospitalist (Hospitalist CME Series, San

Diego, September 12th, 2005)

Cardiology Urgencies and Emergencies for the Hospitalist (Hospitalist CME Series,

Philadelphia, September 26th, 2005)


Atlanta, October 17th, 2005)


59

Houston, November 7th, 2005)

Renal Angioplasty only if BP is uncontrolled– (Coronary Artery Disease 2006, January

13th, Mumbai, India)

Aggressive platelet Inhibition is must in Diabetes with CAD (Coronary Artery Disease

2006, January 13th, Mumbai, India)

Angiogenesis and regeneration of heart muscles in management of Heart failure –

(Coronary Artery Disease 2006, January 15th, Mumbai, India)

Interventional treatment of peripheral arterial Disease (Innovations in intervention, 55 th

Scientific Sessions of the American College of Cardiology, Atlanta, Georgia, March 12th,

2006)

COX-2 Inhibitors and Cardiovascular Risk, Co-Chair (55th Scientific Sessions of the

American College of Cardiology, Atlanta, Georgia, March 13th, 2006)

Tips for Safe and Effective Carotid Stenting, (Meet the Experts @ the 55th Scientific

Sessions of the American College of Cardiology, Atlanta, Georgia, March 13th, 2006)

The Management of Peripheral Arterial Disease (Cardiovascular Medicine and Surgery:

The latest in medications and Techniques, Southern Kentucky AHEC, April 11, 2006)

Pathogenesis, Diagnosis, Treatment and Prevention of Heparin-induced

Thrombocytopenia (American College of Cardiology Conversation with Experts, April

12, 2006) http://conversations.acc.org/

Reperfusion Strategies in patients with STEMI (Cardiology Grand Rounds, Harper

University Hospital, Detroit, Michigan, April 13th, 2006)

60

http://conversations.acc.org/

http://conversations.acc.org/modules/conv/acc/0406b/main.asp

http://conversations.acc.org/modules/conv/acc/0406b/main.asp

Management of patients with STEMI: Applying the ACC/AHA Guidelines (Cardiology

Grand Rounds, Rosalind Franklin University of Medicine, Chicago, Illinois, May 24 th,

2006)

STEMI Management: An Emergency Department Perspective (Internal Medicine Grand

Rounds, CGH Medical Center, Sterling, Illinois, June 7th, 2006)

Interventional Treatment of Peripheral Arterial Disease. (Appalachian Regional

Healthcare, Medical Staff Update, Whitesburg, Kentucky, June 13, 2006)

Management of patients with STEMI: Applying the ACC/AHA Guidelines (Internal

Medicine Grand Rounds, Norman Regional Hospital, Oklahoma City, Oklahoma, June

15th, 2006)

Carotid Artery Stenting. (International College of Surgeons, 68th Annual Surgical

Update, Nashville, Tennessee, June 23rd, 2006)

Cardiology Update (University of Kentucky Internal Medicine Grand Rounds, August

11th, 2006)

Interventional Treatment of Peripheral Arterial Disease. (Boyle County Medical Society,

Danville, Kentucky, August 15th, 2006)

STEMI Management: An Emergency Department Perspective (Internal Medicine Grand

Rounds, Blessing Hospital, Quincy, Illinois, August 16th, 2006)

Reperfusion Strategies in patients with STEMI (Cardiology Grand Rounds, Good

Samaritan Hospital, Dayton, Ohio, August 23rd, 2006)

Non ST segment elevation myocardial infarction: Concept Diagnosis and Treatment.

(Med Congress – International Medical Congress, Shanghai, China, September 17th,

61

2006)

Chronic Total occlusion of a coronary artery and percutaneous coronary intervention.

(Med Congress – International Medical Congress, Shanghai, China, September 17th,

2006)

Aspirin and Clopidogrel resistance in ACS – Is it relevant in Clinical Practice? (Coronary

Artery Disease 2006, September 29th, Mumbai, India)

IIb/IIIa inhibitor in ACS patients – US Perspective (Coronary Artery Disease

Symposium 2006, September 30th, Mumbai, India)

Are IIb/IIIa inhibitors replaced in ACS (Coronary Artery Disease 2006, September 30 th,

Mumbai, India)

Diabetes and CAD – Preventing Progression of Atherosclerosis is the real challenge

(Coronary Artery Disease 2006, October 1st, Mumbai, India)

Treatment of In-Stent Restenosis by a Paclitaxel Coated Balloon Catheter -

PACCOCATH ISR II Trial-Discussant (American Heart Association, November 13th,

2006, Chicago, IL)


Medicine Grand Rounds, Medical Center of Independence, Independence, Missouri,

November 9th, 2006)


Medicine Grand Rounds, Erlanger Medical Center, Chattanooga, Tennessee, November

30th, 2006)


62

Medicine Grand Rounds, Saint Mary’s Hospital, Streator, Illinois, December 19th, 2006)

Peripheral Vascular Disease – Epidemiology, Clinical Features and Management

(Internal Medicine Noon Conference, University of Kentucky, Lexington, Kentucky,

January 4th, 2007)

Managing STEMI: Timing and Decision making in the Emergency Department (Medical

Grand Rounds, Shawnee Mission Medical Center, Shawnee Mission, Kansas, January

16th, 2007)

Management of Peripheral Arterial Disease (Meeting the Challenges to improve

Cardiovascular Outcomes, Southern Kentucky AHEC, Corbin, KY, February 22, 2007)

Vertebral Artery Intervention (American College of Cardiology/i2 Symposium, 56th

Annual Scientific Sessions, New Orleans, Louisiana, March 25, 2007)

Pitfalls in Vascular Ultrasound (Meet the Experts, American College of Cardiology, 56th

Annual Scientific Sessions, New Orleans, Louisiana, March 26, 2007)

Beta-Blockers, Clonidine and Calcium-Channel Blockers Perioperatively - Perioperative

Evaluation of the Cardiac Patient (Meet the Experts, American College of Cardiology,

56th Annual Scientific Sessions, New Orleans, Louisiana, March 27, 2007)

Nonsteroidal Anti-Inflammatory Drugs and the Heart: What Is the Danger? (Meet the

Experts, American College of Cardiology, 56th Annual Scientific Sessions, New Orleans,

Louisiana, March 27, 2007)

Reperfusion Strategies in patients with STEMI (Internal Medicine Grand Rounds, Poplar

Bluff Regional Medical Center, Poplar Bluff, Missouri, April, 20th, 2007)

Combination Secondary Preventive Therapies for Cardiovascular Diseases (How to

63

decrease the odds of developing cardiovascular disease, 16th Annual AHEC Summer

conference, Mt Vernon, June 21, 2007)

Prophylaxis and Management of DVT. Mega Annual Conference of Saviors – Critical

Care Conference, Phuket, Thailand, August 16th, 2007

Emergency management of Acute Coronary syndromes. Mega Annual Conference of

Saviors – Critical Care Conference, Phuket, Thailand, August 16th, 2007

Renal Insufficiency – The Hidden Risk (Coronary Artery Disease 2007, October 5th,

Mumbai, India)

Clinical Risk Scores in ACS (Coronary Artery Disease 2007, October 5th, Mumbai,

India)

Clopidogrel and Stent Thrombosis (Coronary Artery Disease 2007, October 5th, Mumbai,

India)

Managing STEMI in hospitals without PCI (Internal Medicine Grand Rounds, Claremore

Indian Hospital, Claremore, Oklahoma, October 12th, 2007)

Management of patients with STEMI: Applying the ACC/AHA Guidelines (CME

Distinguished Lecture Series, ARH Regional Medical Center, Hazard, Kentucky,

December 5th, 2007)

Pre-Hospital and Emergency Department Management of STEMI (Medical Grand

Rounds, Delta Regional Medical center, Greenville, Mississippi, December 6th, 2007)

How to improve quality in PCI (The 30th annual American College of Cardiology

conference at Big Sky, Feb 21st 2008, Montana)

Drug eluting stents – The truth (The 30th annual American College of Cardiology

64

conference at Big Sky, Feb 22nd 2008, Montana)

An Update on Coronary Artery Disease in the South Asian population. (Annual

Scientific Sessions of the American Association of Cardiologists of Indian origin, March

30th, 2008, Chicago, IL)

Aortic Dissection and Acute Aortic Syndromes (Cardiology Grand Rounds, Medical

College of Wisconsin, Milwaukee, June 3rd, 2008)

65